{
  "meta": {
    "title": "00055_Late_Night_Pyq_Pyt_Marathon_-_55",
    "url": "https://brainandscalpel.vercel.app/00055-late-night-pyq-pyt-marathon-55-adf09a1e.html",
    "scrapedAt": "2025-11-29T17:25:02.667Z"
  },
  "questions": [
    {
      "id": 5746,
      "choices": [
        {
          "id": 22956,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single dose of 0.75 after 12 hrs</span></span></span></p>"
        },
        {
          "id": 22957,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22958,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22959,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For emergency contraception, a single tab of 0.75 mg of LNG was taken, it should be followed by which of the following?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9972601",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609486,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Single dose of 0.75 after 12 hrs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the 2nd dose of LNG 0.75 mg (levonorgestrel) is taken after 12 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One tablet of LNG 0.75mg should be taken within 72 hours of unprotected intercourse and another 12 hours later. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alternately, two tablets (of 0.75mg) or a single 1.5mg tablet can be taken as a single dose. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The tablets can be offered up to 72h of an act of unprotected intercourse, but the efficacy decreases with the longer coital-drug interval.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other emergency contraceptives available: </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-094530.png\" style=\"height:301px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency contraception using levonorgestrel requires a follow-up dose of 0.75 mg taken 12 hours after the initial dose to ensure efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 243, Berek and Novak&rsquo;s Gynecology 15<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20489,
      "choices": [
        {
          "id": 81918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydial infection</span></span></span></p>"
        },
        {
          "id": 81919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscess</span></span></span></p>"
        },
        {
          "id": 81920,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genital Tuberculosis</span></span></span></p>"
        },
        {
          "id": 81921,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes with complaints of pain and swelling in the perineal area, difficulty in walking and sitting. She has a history of multiple sexual partners. On examination, a tender swelling is seen with redness on the labia, as shown in the image given below. What is the most likely diagnosis?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210148.jpg\" style=\"height:347px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8813056",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609487,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bartholin abscess</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical scenario and image points to the diagnosis of Bartholin&#39;s abscess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin Cyst and Abscess</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland is a mucus-secreting gland, which plays a role in vaginal lubrication. They are a pair of 0.5 cm glands located in the lower right and left portions at the 4 o&rsquo;clock and 8 o&rsquo;clock positions of the vaginal introitus. They are generally nonpalpable when not obstructed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathophysiology: Bartholin glands can form a cyst and an abscess in women of reproductive age and may cause dyspareunia, urinary irritation, and vague pelvic pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The physical exam will often reveal asymmetry with a protrusion of one side (left or right) of the inferior aspect of the vulva.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland abscesses, unlike Bartholin cysts, are very painful.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While both are primarily unilateral, Bartholin abscesses are often tender to palpation, erythematous, indurated, and may have an area of fluctuance and/or purulent drainage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic Bartholin cysts do not require further treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscesses may be treated with incision and drainage with Word catheter placement due to ease and effectiveness of treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marsupialization is the procedure of choice.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with recurrent cysts or those who are post-menopausal (risk of malignancy) should have the cyst completely excised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chlamydial infection</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chlamydial infection patient usually present with vaginal discharge, dysuria, or cervicitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Genital tuberculosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital tuberculosis involves the upper genital tract, leading to menstrual irregularities, infertility, and abdominal pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Genital herpes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital herpes usually presents as painful ulcers or vesicles in the genital area, rather than a tender, erythematous swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Bartholin abscess presents with significant pain, redness, and swelling in the labia, often making walking and sitting difficult.</span></span></span></p>",
      "correct_choice_id": 81919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54773,
      "choices": [
        {
          "id": 218557,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Expedite delivery</span></p>"
        },
        {
          "id": 218558,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Wait till 37 weeks</span></p>"
        },
        {
          "id": 218559,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + wait till 37 weeks</span></p>"
        },
        {
          "id": 218560,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + Expedite delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents at 36 weeks with chronic HTN and 3+ proteinuria. Her BP is 170/100 mmHg and she complains of headache and blurring of vision. What is the best management option? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7599765",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609488,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Labetalol + MgSO4 + Expedite delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is presenting with chronic hypertension that has progressed to superimposed preeclampsia, indicated by the development of 3+ proteinuria, a blood pressure of 170/100 mmHg, and symptoms such as headache and blurring of vision. These symptoms and her elevated blood pressure suggest severe preeclampsia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Severe Preeclampsia</strong>: A systolic blood pressure greater than 160 mmHg or a diastolic blood pressure greater than 110 mmHg, along with symptoms like headache and visual disturbances, are indicators of severe preeclampsia. In this case, the patient’s condition requires urgent management to prevent the development of eclampsia, a condition that can lead to seizures and other severe complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management</strong>: The correct management for severe preeclampsia at 36 weeks gestation includes the administration of <strong>Labetalol</strong> to lower the blood pressure, <strong>Magnesium sulfate (MgSO4)</strong> to prevent seizures, and <strong>expedited delivery</strong> to resolve the preeclampsia. After 34 weeks of gestation, delivery is recommended for severe preeclampsia because the risks of continuing the pregnancy outweigh the benefits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Labetalol + MgSO4 + Wait till 37 weeks: </strong>As this is severe preeclampsia, there is a very high risk waiting till 37 weeks. Immediate delivery is indicated after 34 weeks</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Labetalol + Corticosteroids + wait till 37 weeks: </strong>There is no indication for corticosteroids as she has crossed 34 weeks and also there is no indication to wait till 37 weeks as this is severe preeclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Labetalol + Corticosteroids + Expedite delivery:&nbsp;</strong>Although delivery needs to be expedited, there is no indication for corticosteroids as she has crossed 34 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of severe preeclampsia after 34 weeks, immediate delivery, blood pressure control with labetalol, and seizure prophylaxis with magnesium sulfate are essential for optimal maternal and fetal outcomes.</span></p>",
      "correct_choice_id": 218557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5678,
      "choices": [
        {
          "id": 22684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus</span></span></span></p>"
        },
        {
          "id": 22685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulbospongiosus</span></span></span></p>"
        },
        {
          "id": 22686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ischiocavernosus </span></span></span></p>"
        },
        {
          "id": 22687,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superficial transverse perineal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The deepest part of perineal body injury, which causes cystocele, enterocoele and urethral descent is?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q6453522",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609489,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pubococcygeus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus is the deepest part of the levator ani muscle. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Injury to it can cause enterocele, cystocele, and urethral descent.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The levator ani muscles are the most important muscles in the pelvic floor and maintain a constant state of contraction. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weakening of this muscle decreases support for the vagina, bladder, uterus, or rectum or alter the position of the neck of the bladder and urethra.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bulbospongiosus, Option C. ischiocavernosus&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. superficial transverse perineal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are all superficial muscles and their damage does not result in uterovaginal descent</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supports of the vagal have been described by Delancey as shown below and defects in these lead to different levels of uterovaginal prolapse</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in Level 1 support: Vaginal apical prolapse and uterine prolapse</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 2 support: Cystocele and Rectocele</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 3 support: urethrocele and deficient perineal body</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-174103.jpg\" style=\"height:427px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 544, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6052,
      "choices": [
        {
          "id": 24178,
          "text": "<p><span style=\"font-size:12pt;\">Magnesium sulphate toxicity</span></p>"
        },
        {
          "id": 24179,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic ketoacidosis</span></p>"
        },
        {
          "id": 24180,
          "text": "<p><span style=\"font-size:12pt;\">Postpartum eclampsia</span></p>"
        },
        {
          "id": 24181,
          "text": "<p><span style=\"font-size:12pt;\">Peripartum cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22y type 1 DM is in the post operative ward following a cesarean done for failed induction (for preeclampsia with severe features). She complains of drowsiness and altered sensorium. She is on maintenance MgSO4 infusion and on IV infusion of insulin. On examination, her PR is 70/ min. BP is 140/ 98 mmHg. RR is 10/min. Auscultation of lungs reveals bilateral normal air entry. Abdominal examination reveals a firm uterus with normal tenderness. Pfannenstiel scar is intact and there is no significant vaginal bleeding. B/l patellar reflexes are absent. A urine dipstick for protein and sugar is negative and a capillary glucose sample is 270 mg%. The suspected diagnosis is?&nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q3994813",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609490,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Magnesium sulphate toxicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical scenario and examination finding of B/L absent knee reflex and respiratory depression following magnesium sulfate (MgSO4) administration for preeclampsia suggest the cause of her condition to be magnesium sulfate toxicity.</span></li><li><span style=\"font-size:12pt;\">MgSO4 is used as an anticonvulsant in the management of eclampsia and as prophylaxis in severe preeclampsia.</span></li><li><span style=\"font-size:12pt;\">The therapeutic level of magnesium in eclampsia is 4-7 mEq/L</span></li><li><span style=\"font-size:12pt;\">When on MgSO4, patients must be monitored for magnesium toxicity:</span></li><li><span style=\"font-size:12pt;\">A woman on MgSO4 for management of eclampsia requires the following to be checked for Mg toxicity:</span><ol><li><span style=\"font-size:12pt;\">Deep tendon reflexes</span></li><li><span style=\"font-size:12pt;\">Respiratory Rate</span></li><li><span style=\"font-size:12pt;\">Urine Output</span></li></ol></li><li><span style=\"font-size:12pt;\">Magnesium toxicity occurs at these levels</span><ul><li><span style=\"font-size:12pt;\">At &gt; 7-10 mEq/L: Loss of DTR</span></li><li><span style=\"font-size:12pt;\">10 - 12 mEq/L: Respiratory depression</span></li><li><span style=\"font-size:12pt;\">25 mEq/L: Cardiac arrest</span></li></ul></li><li><span style=\"font-size:12pt;\">Antidote for Mg toxicity: Ca gluconate (1 g IV)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic ketoacidosis</strong>: This is unlikely as urine for sugars is absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Postpartum eclampsia</strong>: This is unlikely as there is no history of seizures</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Peripartum cardiomyopathy</strong>: There is no evidence of cardiac failure and hence this is also unlikely</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When administering magnesium sulfate for preeclampsia, it is critical to monitor for signs of magnesium toxicity, which include loss of deep tendon reflexes, respiratory depression, and cardiac arrest. The antidote for magnesium toxicity is calcium gluconate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1860, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61195,
      "choices": [
        {
          "id": 244061,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">400 micrograms</span></span></span></p>"
        },
        {
          "id": 244062,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">600 micrograms</span></span></span></p>"
        },
        {
          "id": 244063,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">800 micrograms</span></span></span></p>"
        },
        {
          "id": 244064,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1000 micrograms</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What dose of misoprostol is administered orally to manage post-partum hemorrhage? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q5504428",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609491,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. 600 micrograms</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The recommended oral dose of misoprostol for the emergent management of postpartum hemorrhage is 600 micrograms. Studies have shown that administering 600 micrograms of misoprostol at the time of delivery significantly reduces the incidence of hemorrhage and severe hemorrhage. Misoprostol is a synthetic prostaglandin E1 analogue, effective in preventing and treating uterine atony and postpartum hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. 400 micrograms</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This dose is less effective in controlling postpartum hemorrhage compared to 600 micrograms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. 800 micrograms</strong> - Although higher doses may be used, 600 micrograms is the standard recommended dose for oral administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D. 1000 micrograms</strong> - This dose is not commonly recommended for oral administration in managing postpartum hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The standard oral dose of misoprostol for controlling postpartum hemorrhage is 600 micrograms</span></span></span></p>",
      "correct_choice_id": 244062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23225,
      "choices": [
        {
          "id": 92864,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases risk of Colon cancer</span></span></span></p>"
        },
        {
          "id": 92865,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of breast cancer</span></span></span></p>"
        },
        {
          "id": 92866,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of endometrial cancer</span></span></span></p>"
        },
        {
          "id": 92867,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases risk of osteoporosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true association related to HRT (Hormone replacement therapy) among the options provided?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q6606855",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609492,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Decreases risk of Colon cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) has been associated with a decreased risk of colon cancer. Studies have shown that estrogen in HRT may have a protective effect against the development of colon cancer. This effect is believed to be related to estrogen&rsquo;s impact on gastrointestinal mucosal growth and repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased risk of breast cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT, particularly with estrogen and progestin, is associated with an increased risk of breast cancer. Long-term use of combined HRT has been shown to elevate the risk of breast cancer in several studies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased risk of endometrial cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. Unopposed estrogen (estrogen alone without progestin) increases the risk of endometrial cancer. To mitigate this risk, progestin is often added to HRT in women with an intact uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increases risk of osteoporosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT is actually used prophylactically to reduce the risk of osteoporosis. Estrogen helps maintain bone density and prevent bone loss, which is beneficial in managing osteoporosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) decreases the risk of colon cancer.</span></span></span></p>",
      "correct_choice_id": 92864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5795,
      "choices": [
        {
          "id": 23151,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></p>"
        },
        {
          "id": 23152,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 19, 23, 33, 45, 58</span></p>"
        },
        {
          "id": 23153,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></p>"
        },
        {
          "id": 23154,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against which of the following serotypes?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q2700026",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609493,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV Vaccines available are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Cervarix (Bivalent): 16, 18</span></li><li><span style=\"font-size:12pt;\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></li><li><span style=\"font-size:12pt;\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18,31,33,45,52,58.</span></li><li><span style=\"font-size:12pt;\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6,11,16,18</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against serotypes <strong>6, 11, 16, 18, 31, 33, 45, 52, 58.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule</u></strong></span></a></p>",
      "correct_choice_id": 23154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44007,
      "choices": [
        {
          "id": 175687,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by radiotherapy</span></p>"
        },
        {
          "id": 175688,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by chemotherapy</span></p>"
        },
        {
          "id": 175689,
          "text": "<p><span style=\"font-size:12pt;\">Chemotherapy followed by debulking</span></p>"
        },
        {
          "id": 175690,
          "text": "<p><span style=\"font-size:12pt;\">Staging laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman with epithelial ovarian cancer has peritoneal metastases and ascites. What is the management?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q1393497",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609494,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Debulking followed by chemotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For advanced ovarian cancer with peritoneal metastases and ascites, the preferred treatment is surgical debulking followed by chemotherapy. This approach helps reduce tumor load and enhances chemotherapy effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Debulking followed by radiotherapy:</strong> Radiotherapy is not typically used as a first-line treatment in ovarian cancer with peritoneal metastases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Chemotherapy followed by debulking:</strong> Starting with chemotherapy may be considered, but debulking first is usually preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Staging laparotomy:</strong> Staging laparotomy is primarily diagnostic, not therapeutic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In advanced epithelial ovarian cancer with peritoneal involvement, initial surgical debulking followed by chemotherapy is the standard management approach to maximize treatment efficacy.</span></p>",
      "correct_choice_id": 175688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61201,
      "choices": [
        {
          "id": 244085,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uterocervical prolapse</span></span></span></p>"
        },
        {
          "id": 244086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic organ prolapse with rectocele</span></span></span></p>"
        },
        {
          "id": 244087,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic organ prolapse with cystocele</span></span></span></p>"
        },
        {
          "id": 244088,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal vault prolapse</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 68-year-old postmenopausal woman visits the gynecology clinic with complaints of a sensation of heaviness and a visible bulge protruding from her vaginal opening, which she first noticed several years ago but has progressively worsened. She describes intermittent urinary incontinence, difficulty emptying her bladder, and recent constipation, which she attributes to the pressure she feels in her lower abdomen. She denies any recent trauma or significant weight gain but mentions a history of multiple vaginal deliveries. The patient has no history of pelvic surgery. On pelvic examination, a mass is visible protruding beyond the vaginal introitus, and the cervix is noted to be at or beyond the level of the vaginal opening. What is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q1754594",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609495,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: A. Uterocervical prolapse</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uterocervical prolapse occurs when the uterus and cervix descend into the vaginal canal due to weakened pelvic floor muscles and ligaments, often caused by factors such as multiple vaginal deliveries, advancing age, and postmenopausal hypoestrogenism. This condition typically presents with symptoms of pelvic pressure, a visible protruding mass at the vaginal introitus, urinary incontinence, and bowel dysfunction, as observed in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pelvic organ prolapse with rectocele</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rectocele refers to the herniation of the rectum into the posterior vaginal wall, commonly presenting as a posterior bulge that causes symptoms of constipation and difficulty with bowel movements. Unlike uterocervical prolapse, it does not involve the descent of the cervix or uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Pelvic organ prolapse with cystocele</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Cystocele involves the protrusion of the bladder into the anterior vaginal wall, often presenting with urinary symptoms such as urgency, frequency, and stress incontinence. The physical examination would reveal a bulge from the anterior vaginal wall rather than the centrally positioned mass seen with uterocervical prolapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Vaginal vault prolapse</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Vaginal vault prolapse occurs in patients who have undergone a hysterectomy, leading to the descent of the vaginal apex. It typically presents with pelvic pressure and a vaginal bulge but lacks the specific involvement of the cervix and uterus seen in uterocervical prolapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uterocervical prolapse is a condition characterized by the descent of the uterus and cervix into the vaginal canal, often seen in postmenopausal women with a history of multiple vaginal deliveries. It presents with pelvic pressure, visible protrusion from the vaginal introitus, and associated urinary and bowel symptoms, necessitating appropriate clinical evaluation and management.</span></span></span></p>",
      "correct_choice_id": 244085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5880,
      "choices": [
        {
          "id": 23490,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphine citrate</span></span></span></p>"
        },
        {
          "id": 23491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole</span></span></span></p>"
        },
        {
          "id": 23492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></span></span></p>"
        },
        {
          "id": 23493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic ovarian drilling</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can be used for the treatment of PCOD except?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q3179558",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609668,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ulipristal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal is not used for the treatment of PCOD. </span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a selective progesterone receptor modulator.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used as an emergency contraceptive and in medical management of fibroids</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clomiphene</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Clomiphene is an anti-estrogen used in ovulation induction in women with PCOS (1<sup>st</sup> line agent) and infertility</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadotropins can also be used in PCOS with infertility in those who have clomiphene resistance (2<sup>nd</sup> line therapy)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Letrozole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: But nowadays Letrozole (aromatase inhibitor) is the drug for ovulation induction in PCOS with infertility. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Laparoscopic ovarian drilling:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is recommended as second-line therapy in PCOS</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is not used for the treatment of Polycystic Ovary Syndrome (PCOS). It is a selective progesterone receptor modulator primarily used for emergency contraception and managing uterine fibroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 244, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5900,
      "choices": [
        {
          "id": 23570,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 23571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis</span></span></span></p>"
        },
        {
          "id": 23572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leiomyoma</span></span></span></p>"
        },
        {
          "id": 23573,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presented with a lower abdominal mass and lower abdominal discomfort. On examination, the uterus appears uniformly enlarged and adnexa is free. MRI shows the presence of a myometrial cyst. What is the most probable diagnosis?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q5804087",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609669,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Adenomyosis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis is the presence of endometrial tissue in the myometrium. The uterus is generally uniformly enlarged up to 12-14 weeks size and can be tender on examination. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Investigation of choice: Ultrasound</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On ultrasound, the following can be seen in adenomyosis:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-70.jpg\" style=\"height:277px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of adenomyosis</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management: For symptomatic relief</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total Hysterectomy (Definitive treatment - Treatment of choice if family is complete)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Endometriosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This presents as 5Ds (Dysmenorrhoea, Dyspareunia, Dyschezia, Dysfertility and Dull-aching abdominal pain). Diagnostic modality of choice is laparoscopy. Myometrial cysts are not seen. Endometriotic (chocolate) cysts in the ovary may be seen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Leiomyoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fibroids or leiomyomas usually present with menorrhagia and dysmenorrhoea. If very large, they will present with abdominal mass and pelvic pressure. On ultrasound, depending on the location, well circumscribed rounded lesions are seen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Endometrial hyperplasia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This will present as menorrhagia. On ultrasound the endometrium will be thickened. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis is characterized by a uniformly enlarged uterus with myometrial cysts, diagnosed primarily via ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 196, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6009,
      "choices": [
        {
          "id": 24006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandins play an important role. Thromboxane A2 decreases; Prostacyclin: Thromboxane ratio increases in preeclampsia</span></span></span></p>"
        },
        {
          "id": 24007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell dysfunction leads to reduced nitric oxide levels and this causes the clinical presentation of preeclampsia</span></span></span></p>"
        },
        {
          "id": 24008,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasoconstriction leads to ischemia, necrosis and hemorrhage and end organ damage seen in preeclampsia</span></span></span></p>"
        },
        {
          "id": 24009,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-angiogenic factors play an important role in preeclampsia. There is an increase in FIt-1 and decrease in PIGF</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are theories of causation of preeclampsia except:&nbsp;</span></span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q6263408",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609670,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prostaglandins play an important role. Thromboxane A2 decreases; Prostacyclin: Thromboxane ratio increases in preeclampsia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are theories of causation of preeclampsia except option A. There is reduced or absent prostacyclin (PGI,) production with increased production of thromboxane (TXA,) and reduced ratio of prostacyclin: thromboxane in preeclampsia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endothelial cell dysfunction leads to reduced nitric oxide levels and this causes the clinical presentation of preeclampsia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell dysfunction is another etiology. Injured or activated endothelial cells may produce less nitric oxide and may secrete substances that promote coagulation and vasopressor sensitivity. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vasoconstriction leads to ischemia, necrosis and hemorrhage and end organ damage seen in preeclampsia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasospasm has long been associated with preeclampsia. Systemic endothelial activation causes vasospasm, which elevates resistance to produce hypertension. With diminished blood flow because of maldistribution from vasospasm and interstitial leakage, ischemia of the surrounding tissues can cause necrosis, hemorrhage, and other end-organ disturbances. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Anti-angiogenic factors play an important role in preeclampsia. There is an increase in FIt-1 and decrease in PIGF:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiogenic Factors: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental vasculogenesis is evident 21 days after conception. Two antiangiogenic peptides that are increased</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Soluble fms-like tyrosine kinase 1 (s-flt-1)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Soluble endoglin (s-eng)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factors that are decreased are</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PlGF</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAPP-A</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VEGF</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-237.jpg\" style=\"height:407px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In preeclampsia, the prostacyclin: thromboxane ratio is decreased due to increased thromboxane A2 and decreased prostacyclin (PGI2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1802, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5816,
      "choices": [
        {
          "id": 23234,
          "text": "<p><span style=\"font-size:12pt;\">Radical vulvectomy with unilateral LN dissection</span></p>"
        },
        {
          "id": 23235,
          "text": "<p><span style=\"font-size:12pt;\">Radical vulvectomy with bilateral LN dissection</span></p>"
        },
        {
          "id": 23236,
          "text": "<p><span style=\"font-size:12pt;\">Simple vulvectomy</span></p>"
        },
        {
          "id": 23237,
          "text": "<p><span style=\"font-size:12pt;\">Chemoradiation with resection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old female presented with a non-healing ulcer on the labia majora for a period of 6 months, measuring 2 cm x 3 cm. No lymph nodes were palpable. Biopsy shows squamous cell carcinoma. How do you manage this case?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q2514297",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609671,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Radical vulvectomy with bilateral LN dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This patient has a midline lesion on the labia majora, which indicates that the lesion is close to or crossing the midline. In cases of midline lesions or lesions within 2 cm of the midline, bilateral inguinofemoral lymph node dissection is necessary along with radical vulvectomy. This approach ensures that all potential pathways of lymphatic spread are adequately addressed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>New (2021) FIGO staging for carcinoma of the vulva:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Tumors 2 cm or less in size with 1 mm or less invasion:</strong> Treated by wide local excision.</span></li><li><span style=\"font-size:12pt;\"><strong>Tumors more than 2 cm with more than 1 mm depth of invasion:</strong> Treated by modified radical vulvectomy with groin lymph node dissection.</span></li><li><span style=\"font-size:12pt;\"><strong>LN dissection through separate incision:</strong> Lymph node dissection should be inguino-femoral.</span></li><li><span style=\"font-size:12pt;\"><strong>Bilateral lymph node dissection:</strong> Performed for midline lesions and those within 2 cm of the midline.</span></li><li><span style=\"font-size:12pt;\"><strong>Unilateral dissection:</strong> If the lesion is unilateral and ipsilateral nodes are negative, bilateral dissection is not necessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Radical vulvectomy with unilateral LN dissection:</strong> This would be appropriate for unilateral lesions with no evidence of contralateral spread, but not for midline lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Simple vulvectomy:</strong> Simple vulvectomy is not sufficient for managing invasive squamous cell carcinoma with a lesion size of 2 cm x 3 cm and potential for deeper invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Chemoradiation with resection:</strong> Chemoradiation followed by resection is typically reserved for advanced or inoperable cases, or where there is a need to downstage the tumor before surgery. This case can be managed surgically given the size and lack of palpable lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For midline lesions or lesions within 2 cm of the midline in squamous cell carcinoma of the vulva, radical vulvectomy with bilateral inguinofemoral lymph node dissection is the appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: FIGO staging of CA vulva, Berek and Novak’s gynecology 15<sup>th</sup> edition pg 1436, William’s textbook of gynecology 3rd edition pg 484-485.</strong></span></p>",
      "correct_choice_id": 23235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6074,
      "choices": [
        {
          "id": 24265,
          "text": "<p><span style=\"font-size:12pt;\">Mifepristone + misoprostol</span></p>"
        },
        {
          "id": 24266,
          "text": "<p><span style=\"font-size:12pt;\">Manual vacuum aspiration</span></p>"
        },
        {
          "id": 24267,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation and evacuation</span></p>"
        },
        {
          "id": 24268,
          "text": "<p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following can be used in first-trimester medical termination of pregnancy (MTP), except:&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q2151200",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609672,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Extra-amniotic instillation of ethacridine lactate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Extra-amniotic instillation of ethacridine lactate</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">This method is typically used for second-trimester abortions. It involves the instillation of ethacridine lactate into the extra-amniotic space to induce abortion. However, it is rarely used nowadays due to advancements in other safer and more effective methods.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Medical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Mifepristone + misoprostol</strong>: A combination of mifepristone (a progesterone receptor antagonist) and misoprostol (a prostaglandin analog) is a common and effective method for first-trimester medical termination of pregnancy.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Surgical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Manual vacuum aspiration</strong>: This is a safe and effective method for terminating a pregnancy in the first trimester.</span></li><li><span style=\"font-size:12pt;\"><strong>Dilatation and curettage</strong>: Another surgical method used to evacuate the contents of the uterus in the first trimester.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mifepristone + misoprostol</strong>: Mifepristone + misoprostol is a commonly used combination for medical termination in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual vacuum aspiration</strong>: Manual vacuum aspiration is a standard procedure for first-trimester abortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Dilatation and evacuation</strong>: Dilatation and evacuation is another method used in the first trimester to terminate a pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate is not used for first-trimester medical termination of pregnancy (MTP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg364,369, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg203</strong></span></p>",
      "correct_choice_id": 24268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61196,
      "choices": [
        {
          "id": 244065,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">200 mL</span></span></span></p>"
        },
        {
          "id": 244066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">300 mL</span></span></span></p>"
        },
        {
          "id": 244067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">500 mL</span></span></span></p>"
        },
        {
          "id": 244068,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1000 mL</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The maximum capacity of a Bakri balloon used in postpartum hemorrhage? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q7430813",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609673,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: C. 500 mL</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Bakri balloon is designed to manage postpartum hemorrhage by tamponading the uterine cavity to stop bleeding. Its maximum capacity is 500 mL. During the procedure, the balloon is initially inflated with at least 150 mL of fluid and then gradually increased to a total volume of 300 to 500 mL to effectively control hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A. 200 mL</strong> - This is below the maximum capacity and may not be sufficient to control severe hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B. 300 mL</strong> - Although part of the inflation process, it is not the maximum capacity.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">d. 1000 mL - This exceeds the designed capacity of the Bakri balloon.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Bakri balloon can hold up to 500 mL of fluid to effectively manage postpartum hemorrhage</span></span></span></p>",
      "correct_choice_id": 244067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5966,
      "choices": [
        {
          "id": 23834,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 23835,
          "text": "<p><span style=\"font-size:12pt;\">Laparoscopy and metroplasty</span></p>"
        },
        {
          "id": 23836,
          "text": "<p><span style=\"font-size:12pt;\">Hysteroscopy and septoplasty</span></p>"
        },
        {
          "id": 23837,
          "text": "<p><span style=\"font-size:12pt;\">Laparotomy and metroplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old married woman who came for the evaluation of infertility was found to have a septum in her uterine cavity. What would be the appropriate management of this case? (NEET PG 2021)</span></p>",
      "unique_key": "Q7432914",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609674,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hysteroscopy and septoplasty</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>&nbsp;Hysteroscopy and septoplasty:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Uterine septum is a Mullerian anomaly where the uterine cavity is completely or partially separated by a septum. This can lead to infertility, recurrent abortions, preterm labor, fetal growth restriction, malpresentations, and retained placenta.</span></li><li><span style=\"font-size:12pt;\">The diagnosis of a uterine septum can be confirmed through hysterosalpingography (HSG), 3D ultrasound, MRI, or hysteroscopy. Hysteroscopy is the gold standard for both diagnosis and treatment.</span></li><li><span style=\"font-size:12pt;\">Hysteroscopic resection (septoplasty) is the appropriate management as it involves minimally invasive surgery to remove the septum, which improves reproductive outcomes.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/6.jpg\" alt=\"\" width=\"700\" height=\"298\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hysterectomy:</strong> Hysterectomy, the removal of the uterus, is not an appropriate management for a uterine septum in a woman desiring fertility. This would completely eliminate her ability to conceive and carry a pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Laparoscopy and metroplasty:</strong> While laparoscopy can be used to visualize the external uterine anatomy, metroplasty (surgical correction of the uterus) is better performed via hysteroscopy for a uterine septum. Laparoscopy is more invasive and not the first-line approach for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Laparotomy and metroplasty:</strong> Laparotomy is an open surgical procedure that involves a larger incision in the abdomen. This approach is unnecessarily invasive for the correction of a uterine septum, which can be effectively managed with a less invasive hysteroscopic approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The appropriate management of a uterine septum, especially in a woman seeking fertility, is hysteroscopic resection (septoplasty), which involves minimally invasive surgery to remove the septum and improve reproductive outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 47, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23836,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5930,
      "choices": [
        {
          "id": 23690,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 23691,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 23692,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 23693,
          "text": "<p><span style=\"font-size:12.0pt;\">0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida is in labour. Her per-vaginal examination revealed a posterior cervix with 5 cm cervical length, 1 cm dilatation, soft consistency, and head at -1 station. Calculate the modified Bishop score?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q3203291",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609675,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Bishop Score</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The 5 components of the Modified Bishop score are:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Cervical Dilatation</span></li><li><span style=\"font-size:12.0pt;\">Cervical length</span></li><li><span style=\"font-size:12.0pt;\">Cervical consistency</span></li><li><span style=\"font-size:12.0pt;\">Cervical Position</span></li><li><span style=\"font-size:12.0pt;\">Station of the presenting part</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Easy to remember Mnemonic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">B – Bishop</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I – Effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">S – Station of presenting part</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H – Hard/ soft (consistency)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">O – Os dilatation (cervical dilatation)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">P – Position of the cervix</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12.0pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12.0pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12.0pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-226_ZlB06tA.jpg\" alt=\"\" width=\"900\" height=\"473\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Modified Bishop score is used to assess the cervix's favorability for induction, and a score of 5 in this context would be based on specific factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5847,
      "choices": [
        {
          "id": 23358,
          "text": "<p><span style=\"font-size:12pt;\">VIA</span></p>"
        },
        {
          "id": 23359,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿VILI</span></p>"
        },
        {
          "id": 23360,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿PAP smear</span></p>"
        },
        {
          "id": 23361,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Colposcopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following instrument is used for……:&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xZqzTuR.jpg\" alt=\"\" width=\"300\" height=\"51\"></span></p>",
      "unique_key": "Q2624712",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609676,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) PAP smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shown is that of Ayre's spatula which is used for preparing PAP smear.</span></li><li><span style=\"font-size:12pt;\">It is used to scrape the squamocolumnar junction of the cervix while preparing a Pap smear.</span></li><li><span style=\"font-size:12pt;\">A cytobrush is used to take endocervical samples</span></li><li><span style=\"font-size:12pt;\">The smear is fixed with 95% ethanol</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. VIA</strong>: This is Visual Inspection under Acetic Acid. This is done by applying acetic acid on the cervix. Any acetowhite area is suspicious for dysplasia. It is done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. VILI</strong>: Visual inspection under Lugol Iodine: This is done by applying Lugol’s iodine on the cervix. A dysplastic area will not take up iodine. It is also done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-175609.png\" alt=\"\" width=\"500\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Colposcopy</strong>: This is a magnified view of the cervix. It is done in patients with abnormal pap smear/ HPV +Ve/ VIA +ve or VILI +ve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ayre's spatula is used for preparing a Pap smear by scraping cells from the cervix for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 325, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5982,
      "choices": [
        {
          "id": 23898,
          "text": "<p><span style=\"font-size:12pt;\">Pap smear</span></p>"
        },
        {
          "id": 23899,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Hysteroscopy</span></p>"
        },
        {
          "id": 23900,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Biopsy</span></p>"
        },
        {
          "id": 23901,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Dilatation and curettage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The following set of instruments are used for which procedure?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2021-1.jpg\" alt=\"\" width=\"300\" height=\"236\"></p>",
      "unique_key": "Q4199335",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609677,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pap smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given set of instruments are commonly used for taking a Pap smear. The instruments include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cusco's bivalved self-retaining speculum:</strong> Used to visualize the cervix.</span></li><li><span style=\"font-size:12pt;\"><strong>Koplin's jar:</strong> Used to store the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Slides to prepare the smear:</strong> Used for placing the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Ayer's spatula and endocervical brush:</strong> Used to collect cells from the ectocervix and endocervix, respectively.</span></li><li><span style=\"font-size:12pt;\"><strong>Fixative containing 95% ethanol:</strong> Used to preserve the collected sample on the slides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysteroscopy:</strong> This procedure involves using a hysteroscope to visualize the inside of the uterine cavity, and the instruments shown are not used for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Biopsy:</strong> While some of these instruments might be used in a cervical biopsy, the specific combination shown is typically for a Pap smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation and curettage:</strong> This procedure involves dilating the cervix and scraping the endometrial lining, which requires different instruments than those shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The set of instruments shown, including Cusco's speculum, Koplin's jar, slides, Ayer's spatula, endocervical brush, and fixative, are used for performing a Pap smear to collect and preserve cervical cell samples for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23898,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5876,
      "choices": [
        {
          "id": 23474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 23475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 23476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">13 to 20 weeks</span></span></span></p>"
        },
        {
          "id": 23477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 to 28 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risk of fetal varicella syndrome is maximum when the mother is infected between:&nbsp;</span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q1066006",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609678,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 13 to 20 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Varicella Zoster Virus (VZV) is a double-stranded DNA virus that is primarily acquired in childhood and causes chickenpox. The virus is transmitted through direct contact with an infected individual. Nonimmune pregnant women who come into close contact with a patient with chickenpox are at risk of contracting the infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a pregnant woman contracts chickenpox, particularly early in pregnancy, there is a risk of congenital varicella syndrome in the fetus. The highest risk period for the development of congenital varicella syndrome is between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital varicella syndrome includes the following features:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorioretinitis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microphthalmia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebral cortical atrophy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal growth restriction</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydronephrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Limb hypoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cicatricial skin lesions</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the fetus or neonate is exposed to active VZV infection just before or during delivery (less than 5 days before and up to 2 days after delivery), there is a significant risk of disseminated disease and CNS involvement in the neonate, with a mortality rate of approximately 30%. In such cases, administration of VZIG (Varicella-Zoster Immune Globulin) is recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The highest risk period for the development of congenital varicella syndrome in a fetus is when the mother is infected with Varicella Zoster Virus between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 3085</span></strong></span></span></p>",
      "correct_choice_id": 23476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5899,
      "choices": [
        {
          "id": 23566,
          "text": "<p><span style=\"font-size:12pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 23567,
          "text": "<p><span style=\"font-size:12pt;\">Placenta previa</span></p>"
        },
        {
          "id": 23568,
          "text": "<p><span style=\"font-size:12pt;\">Hydramnios</span></p>"
        },
        {
          "id": 23569,
          "text": "<p><span style=\"font-size:12pt;\">Preterm labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A hypertensive pregnant woman with abdominal pain, bleeding per vaginum, and loss of fetal movements. What is the probable diagnosis?&nbsp;</span>(INICET NOV 2020)</p>",
      "unique_key": "Q7329645",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609679,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Abruptio placenta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placentae, also known as placental abruption, commonly occurs in hypertensive disorders of pregnancy. It is characterized by the premature separation of the placenta from the uterus, leading to painful vaginal bleeding, abdominal pain, and often fetal distress or fetal death. The uterus may be tonically contracted in such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hypertensive Disorders:</strong> Abruptio placentae is frequently associated with hypertensive disorders of pregnancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical Presentation:</strong> Painful vaginal bleeding, abdominal pain, and loss of fetal movements are hallmark signs.</span></li><li><span style=\"font-size:12pt;\"><strong>Uterine Contraction:</strong> The uterus may feel firm and tender, indicating a tonic contraction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Placenta previa:</strong> Placenta previa involves painless vaginal bleeding due to the placenta covering the cervix. It generally does not cause decreased fetal movements unless there is severe bleeding leading to maternal and fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Hydramnios:</strong> Hydramnios (polyhydramnios) involves excessive amniotic fluid and does not typically present with bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Preterm labor:</strong> Preterm labor typically does not present with bleeding and is characterized by regular uterine contractions leading to cervical changes before 37 weeks of gestation. Prematurity in preterm labor is iatrogenic if induced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placenta should be suspected in a hypertensive pregnant woman presenting with painful vaginal bleeding, abdominal pain, and loss of fetal movements, as it is commonly associated with hypertensive disorders and presents with these clinical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Textbook of obstetrics 26<sup>th</sup> edition pg 1944</strong></span></p>",
      "correct_choice_id": 23566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5832,
      "choices": [
        {
          "id": 23298,
          "text": "<p><span style=\"font-size:12pt;\">Biophysical profile</span></p>"
        },
        {
          "id": 23299,
          "text": "<p><span style=\"font-size:12pt;\">Fetal blood sampling</span></p>"
        },
        {
          "id": 23300,
          "text": "<p><span style=\"font-size:12pt;\">Amniospectometry</span></p>"
        },
        {
          "id": 23301,
          "text": "<p><span style=\"font-size:12pt;\">MCA doppler peak systolic velocity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In modern obstetrics, which of the following investigations is used for monitoring the fetus of an Rh- negative sensitized mother? (NEET PG 2020)</span></p>",
      "unique_key": "Q5251471",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609680,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) MCA doppler peak systolic velocity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A Doppler of the middle cerebral artery indirectly gives evidence of fetal anemia</span></li><li><span style=\"font-size:12pt;\">An anemic fetus (For e.g. due to fetal red cell destruction in an Rh iso-immunized mother) will re-direct blood flow to more important organs like the brain.</span></li><li><span style=\"font-size:12pt;\">This is reflected by an increased flow in the middle cerebral artery which can be measured by doing a Doppler of the MCA</span></li><li><span style=\"font-size:12pt;\">In Rh immunized mothers, when indirect Coomb’s Test (ICT) titers rise above the critical titer of 1:16, then MCA doppler peak systolic velocity (PSV) is used for monitoring fetal anemia and development of hydrops in these babies.</span></li><li><span style=\"font-size:12pt;\">MCA-PSV has replaced amniocentesis as it is a non-invasive test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Biophysical Profile</strong>: Biophysical Profile is a test of antepartum fetal assessment</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Fetal blood sampling or Cordocentesis</strong>: This is done only when the fetal MCA doppler shows a peak systolic velocity of &gt; 1.5 MoMs</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amnio-spectrometry</strong>: This is no longer done as it is an invasive method of measuring the amount of bilirubin in the amniotic fluid to determine the level of fetal anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MCA Doppler peak systolic velocity is used to monitor fetal anemia in Rh-negative sensitized mothers due to its non-invasive nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 931, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44009,
      "choices": [
        {
          "id": 175695,
          "text": "<p><span style=\"font-size:12pt;\">E1 + E2</span></p>"
        },
        {
          "id": 175696,
          "text": "<p><span style=\"font-size:12pt;\">E6 + E7</span></p>"
        },
        {
          "id": 175697,
          "text": "<p><span style=\"font-size:12pt;\">L1</span></p>"
        },
        {
          "id": 175698,
          "text": "<p><span style=\"font-size:12pt;\">L2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the antigen present in the recombinant HPV vaccine?&nbsp; </span>(INICET NOV 2023)</p>",
      "unique_key": "Q4742046",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609681,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) L1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The recombinant HPV vaccine primarily includes the L1 protein, which self-assembles into virus-like particles, providing the basis for immune recognition without causing the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. E1 + E2:</strong> E1 and E2 are early viral proteins, not included in vaccines due to their role in viral replication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. E6 + E7:&nbsp;</strong>E6 and E7 are proteins involved in oncogenesis, not appropriate for vaccine development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. L2:</strong> L2 is also a capsid protein but not the primary antigen used in current HPV vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The L1 protein of HPV forms the basis of the recombinant HPV vaccine, effectively stimulating an immune response by mimicking the virus structure.</span></p>",
      "correct_choice_id": 175697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6077,
      "choices": [
        {
          "id": 24277,
          "text": "<p><span style=\"font-size:12pt;\">11-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24278,
          "text": "<p><span style=\"font-size:12pt;\">14-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24279,
          "text": "<p><span style=\"font-size:12pt;\">13-year-old girl with Tanner stage 5 breasts</span></p>"
        },
        {
          "id": 24280,
          "text": "<p><span style=\"font-size:12pt;\">12-year-old with Tanner stage 4 breasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following patients would be classified as having primary amenorrhea?</span>&nbsp;(INICET NOV 2022)</p>",
      "unique_key": "Q6263330",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609682,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 14-year-old girl with Tanner stage 1 breasts</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Primary amenorrhea</strong> is defined as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">No menstruation by age 13 in the absence of secondary sexual characteristics.</span></li><li><span style=\"font-size:12pt;\">No menstruation by age 15 in the presence of secondary sexual characteristics.</span></li></ul></li><li><span style=\"font-size:12pt;\">In this context:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Option A</strong>: An 11-year-old girl with Tanner stage 1 breasts would not be classified as having primary amenorrhea since she is not yet 13.</span></li><li><span style=\"font-size:12pt;\"><strong>Option B</strong>: A 14-year-old girl with Tanner stage 1 breasts meets the criteria for primary amenorrhea because she is older than 13 and has no secondary sexual characteristics (Tanner stage 1 breasts).</span></li><li><span style=\"font-size:12pt;\"><strong>Option C</strong>: A 13-year-old girl with Tanner stage 5 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Option D</strong>: A 12-year-old with Tanner stage 4 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 11-year-old girl with Tanner stage 1 breasts</strong>: The girl is too young to be classified as having primary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 13-year-old girl with Tanner stage 5 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 12-year-old with Tanner stage 4 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary amenorrhea is defined as the absence of menstruation by age 13 without secondary sexual characteristics or by age 15 with secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroff’s gynecologic endocrinology 7th edition pg401, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 450</strong></span></p>",
      "correct_choice_id": 24278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6891,
      "choices": [
        {
          "id": 27532,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
        },
        {
          "id": 27533,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lefunamide</span></span></span></p>"
        },
        {
          "id": 27534,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sulphasalazine</span></span></span></p>"
        },
        {
          "id": 27535,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti rheumatoid drug increases extracellular adenosine? (</span></span>AIIMS Nov 2017)</p>",
      "unique_key": "Q2897755",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609683,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Methotrexate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methotrexate works primarily by inhibiting AICAR transformylase and thymidylate synthetase.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AICAR accumulates intracellularly and competes with AMP deaminase, resulting in AMP accumulation. AMP is released and converted extracellularly to adenosine, which is acts as the powerful anti-inflammatory agent. As a result, neutrophils, macrophages, dendritic cells, and lymphocytes&#39; inflammatory functions are suppressed.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Leflunomide:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Leflunomide inhibits dihydroorotate dehydrogenase, which is involved in the de novo synthesis of pyrimidines, thereby suppressing the proliferation of activated lymphocytes. It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sulphasalazine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sulphasalazine is a prodrug that is metabolized into sulfapyridine and 5-aminosalicylic acid (5-ASA). Its anti-inflammatory effects are primarily due to the action of 5-ASA. It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hydroxychloroquine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hydroxychloroquine is thought to exert its anti-inflammatory effects by interfering with lysosomal activity and autophagy in immune cells, and by modulating the activity of toll-like receptors (TLRs). It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate increases extracellular adenosine by inhibiting AICAR transformylase, leading to the accumulation of AICAR, which competes with AMP deaminase and causes AMP to accumulate and be converted to adenosine outside the cell, thus exerting anti-inflammatory effects.</span></span></span></p>",
      "correct_choice_id": 27532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61200,
      "choices": [
        {
          "id": 244081,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immediate surgical removal of the cyst</span></span></span></p>"
        },
        {
          "id": 244082,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start combined oral contraceptives to shrink the cyst</span></span></span></p>"
        },
        {
          "id": 244083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Follow-up with a repeat ultrasound in 6-12 weeks</span></span></span></p>"
        },
        {
          "id": 244084,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measurement of CA-125 levels</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 26-year-old woman with a history of two uncomplicated vaginal deliveries presents to her gynecologist with complaints of dull, aching lower abdominal pain and irregular menstrual cycles for the past few months. She denies any significant weight changes, bowel or urinary symptoms, or family history of ovarian or breast cancer. On pelvic examination, a non-tender mass is palpated in the posterior fornix. A transvaginal ultrasound reveals a 5 x 5 cm unilocular, clear ovarian cyst without solid components or septations. The patient is otherwise healthy and asymptomatic. What is the most appropriate next step in the management of this patient?</span></span></span></p>",
      "unique_key": "Q5849336",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609704,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: C. Follow-up with a repeat ultrasound in 6-12 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clear ovarian cyst described is most likely a functional ovarian cyst, which is common in reproductive-aged women. These cysts are generally benign and often resolve spontaneously. The recommended management for asymptomatic simple ovarian cysts less than 8 cm in size is to monitor the patient with a follow-up ultrasound in 6-12 weeks to confirm resolution. This conservative approach avoids unnecessary interventions in the absence of alarming symptoms or ultrasound features suggestive of malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A. Immediate surgical removal of the cyst</strong>: Surgery is not indicated for a simple, asymptomatic ovarian cyst of this size in a reproductive-aged woman. Surgical intervention is reserved for larger cysts, those with concerning features, or if the cyst persists over time or causes significant symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B. Start combined oral contraceptives to shrink the cyst</strong>: Although often used, oral contraceptive pills have not been proven to hasten the resolution of simple ovarian cysts. Their primary role is to prevent the formation of new cysts rather than resolving existing ones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D. Measurement of CA-125 levels</strong>: CA-125 is a tumor marker used in the evaluation of ovarian masses, but it is not routinely indicated in young women with simple ovarian cysts due to low specificity and the potential for false-positive results from other benign conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The best management for a simple, clear ovarian cyst less than 8 cm in reproductive-aged women is conservative follow-up with repeat ultrasound in 6-12 weeks. Surgery or further investigations are not warranted unless the cyst is large, symptomatic, or has suspicious features.</span></span></span></p>",
      "correct_choice_id": 244083,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20817,
      "choices": [
        {
          "id": 83232,
          "text": "<p><span style=\"font-size:12.0pt;\">Pterygium</span></p>"
        },
        {
          "id": 83233,
          "text": "<p><span style=\"font-size:12.0pt;\">Pinguecula</span></p>"
        },
        {
          "id": 83234,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermoid</span></p>"
        },
        {
          "id": 83235,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermolipoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis in the image given below? (</span>NEET PG 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-111459.jpg\" alt=\"\" width=\"300\" height=\"257\"></span></p>",
      "unique_key": "Q5401029",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609705,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Dermoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ocular dermoids are choristomas, containing tissue not normally found in the area. They often appear as round, firm, and sometimes hair-bearing lesions on the surface of the eye or near the eyelids as given in the image. Dermoids can vary in size and may cause astigmatism if they press against the cornea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pterygium</strong>: This is a benign growth of conjunctival tissue that extends onto the cornea. It often presents as a wedge-shaped, fleshy growth and is usually found on the side closest to the nose. Pterygium is often associated with exposure to sunlight or wind, and its symptoms can include redness, irritation, or a feeling of something in the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pinguecula</strong>: Similar to a pterygium, a pinguecula is a benign, yellowish growth that occurs on the conjunctiva. It typically appears on the side of the eye nearest to the nose but does not grow onto the cornea. Pingueculae are also associated with long-term sun exposure and can cause irritation or dryness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dermolipoma</strong>: This is a type of choristoma, like dermoids, but it primarily consists of fatty tissue. Dermolipomas are usually located on the outer corner of the eye and appear as soft, yellowish masses. They are generally benign and asymptomatic, but their size and location can occasionally cause cosmetic or functional concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognizing and differentiating between various ocular surface lesions is crucial for appropriate diagnosis and management. This involves understanding their typical presentations, etiologies, and potential complications. Regular eye examinations and proper eye protection, especially from UV light, are important for eye health.</span></p>",
      "correct_choice_id": 83234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51495,
      "choices": [
        {
          "id": 205497,
          "text": "<p><span style=\"font-size:12.0pt;\">Chancroid</span></p>"
        },
        {
          "id": 205498,
          "text": "<p><span style=\"font-size:12.0pt;\">Donovanosis</span></p>"
        },
        {
          "id": 205499,
          "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
        },
        {
          "id": 205500,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonorrhoea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug resistance is most seen with which STI?&nbsp;</span>(INICET MAY 2024)</p>",
      "unique_key": "Q8970893",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609706,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Gonorrhoea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Gonorrhoea, caused by the bacterium <i>Neisseria gonorrhoeae</i>, is known for developing significant resistance to multiple antibiotics.</span></li><li><span style=\"font-size:12.0pt;\">Over the years, <i>Neisseria gonorrhoeae</i> has shown resistance to several classes of antibiotics, including penicillin, tetracycline, and fluoroquinolones.</span></li><li><span style=\"font-size:12.0pt;\">More recently, there has been an increasing number of reports of resistance to cephalosporins, including ceftriaxone, which is currently the first-line treatment for Gonorrhoea.</span></li><li><span style=\"font-size:12.0pt;\">The development of drug resistance in Gonorrhoea is largely due to the bacterium's ability to acquire resistance genes through horizontal gene transfer and spontaneous mutations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chancroid</strong>: Chancroid, caused by <i>Haemophilus ducreyi</i>, has not shown the same level of widespread antibiotic resistance as gonorrhoea. It is typically treated with antibiotics such as azithromycin, ceftriaxone, ciprofloxacin, or erythromycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Donovanosis</strong>: Donovanosis, caused by <i>Klebsiella granulomatis</i>, is relatively rare and has not shown significant issues with antibiotic resistance. It is usually treated with azithromycin, doxycycline, or trimethoprim-sulfamethoxazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Syphilis</strong>: Syphilis, caused by <i>Treponema pallidum</i>, is typically treated with penicillin. Although there have been some cases of resistance to macrolides like azithromycin, penicillin remains highly effective, and there is no widespread resistance to it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gonorrhoea is the STI most commonly associated with significant and increasing antibiotic resistance, posing a major challenge to treatment and control efforts worldwide.</span></p>",
      "correct_choice_id": 205500,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5712,
      "choices": [
        {
          "id": 22820,
          "text": "<p><span style=\"font-size:12pt;\">Conization</span></p>"
        },
        {
          "id": 22821,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 22822,
          "text": "<p><span style=\"font-size:12pt;\">Repeat Colposcopy and biopsy after 6 months</span></p>"
        },
        {
          "id": 22823,
          "text": "<p><span style=\"font-size:12pt;\">HPV DNA testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female came for routine PAP smear testing. The report came as HSIL. On colposcopy and biopsy, it was confirmed to be carcinoma in situ. What is the next step?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q5274902",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609707,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Conization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Carcinoma in situ (CIS) of the cervix is classified as Stage 0 cancer. In a young woman with stage 0 cervical cancer, the management of choice is conization. Conization involves the removal of a cone-shaped section of the cervix, including the transformation zone and part of the endocervix. This procedure serves both diagnostic and therapeutic purposes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diagnostic:</strong> Conization provides a tissue specimen for histopathological examination, which is more definitive compared to a cytological specimen obtained from a Pap smear.</span></li><li><span style=\"font-size:12pt;\"><strong>Therapeutic:</strong> If the histopathology shows clear margins, conization can be curative for carcinoma in situ.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysterectomy:</strong> This is a more radical treatment and is generally reserved for cases where there is invasive cancer or other indications. It is not the first-line treatment for CIS in a young woman.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Repeat colposcopy and biopsy after 6 months:</strong> In the case of confirmed carcinoma in situ, conization is preferred. There is no need of repeat colpobiopsy&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. HPV DNA testing:</strong> This test is used for screening and risk assessment but is not a treatment for confirmed carcinoma in situ.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Conization, which involves the removal of a cone-shaped section of the cervix including the transformation zone and part of the endocervix, is the management of choice for carcinoma in situ in young women. It is both diagnostic and therapeutic if histopathology shows clear margins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture2_ByHlD4H.jpg\" alt=\"\" width=\"500\" height=\"354\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 992, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 22820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10183,
      "choices": [
        {
          "id": 40698,
          "text": "<p><span style=\"font-size:12.0pt;\">Light microscopy shows effacement of podocytes</span></p>"
        },
        {
          "id": 40699,
          "text": "<p><span style=\"font-size:12.0pt;\">Good response to steroids</span></p>"
        },
        {
          "id": 40700,
          "text": "<p><span style=\"font-size:12.0pt;\">Most common in adults</span></p>"
        },
        {
          "id": 40701,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-selective proteinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old presents with edema and anasarca. A diagnosis of minimal change disease is made. Which of the following is true about this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q9955075",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609708,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"color:black;font-size:12pt;\"><strong>Ans. B) Good response to steroids</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">Minimal change disease (MCD) is a type of glomerulonephritis that typically affects children and is characterized by the presence of nephrotic syndrome. The following statement is true about this condition:</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Good response to steroids: MCD is often considered to be the most steroid-responsive form of nephrotic syndrome. The vast majority of children with MCD respond well to treatment with corticosteroids, with complete remission of proteinuria and edema occurring in over 90% of cases. However, the response to steroids may be less predictable in adults with MCD.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option A. Light microscopy shows effacement of podocytes</strong>: Electron microscopy shows nonspecific obliteration of epithelial foot processes (not light microscopy)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option C. Most common in adults</strong>: it is common in pediatric age group, not adults</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option D. Non-selective proteinuria</strong>: the patient will have massive nephrotic range proteinuria.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The causes of MCD are mostly idiopathic. It is usually associated with Hodgkin's lymphoma (due to the increased production of cytokines), respiratory infections, prophylactic immunizations, eczema, and rhinitis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture145.jpg\" alt=\"\" width=\"400\" height=\"341\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinically, they mostly present with proteinuria. The child presents with a history of edema that is initially noted around the eyes and gradually progresses into generalized edema. Hypertension and hematuria are uncommon.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture146.jpg\" alt=\"\" width=\"1000\" height=\"422\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children and has a very good response to corticosteroid treatment, resulting in complete remission of proteinuria and edema in over 90% of cases.</span></p>",
      "correct_choice_id": 40699,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23231,
      "choices": [
        {
          "id": 92888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pain begins after few hours of onset of periods and can last up to 48 hours </span></span></span></p>"
        },
        {
          "id": 92889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is dependent on psychological factors </span></span></span></p>"
        },
        {
          "id": 92890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pain begins 3 days prior to the onset of periods and is present up to the second day of the period </span></span></span></p>"
        },
        {
          "id": 92891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GnRH antagonists are the first line of treatment</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these statements regarding primary dysmenorrhea is true?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q6455908",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609709,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) It Is dependent on psychological factors </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary dysmenorrhea can be dependent on psychological factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary dysmenorrhea</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is associated with the presence of pelvic pathologies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pain begins after few hours of onset of periods and can last up to 48 hours</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pain begins 3 days prior to the onset of periods and is present up to the second day of the period</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pain begins before or with onset of menstrual periods. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GnRH antagonists are the first line of treatment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NSAIDs are the first line of treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary dysmenorrhea, characterized by menstrual pain without underlying pelvic pathology, can be influenced by psychological factors. This type of dysmenorrhea begins before or with the onset of menstrual periods and is typically treated first with NSAIDs, not GnRH antagonists.</span></span></span></p>",
      "correct_choice_id": 92889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13038,
      "choices": [
        {
          "id": 52114,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital glaucoma</span></p>"
        },
        {
          "id": 52115,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Retinoblastoma</span></p>"
        },
        {
          "id": 52116,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Congenital hereditary endothelial dystrophy</span></p>"
        },
        {
          "id": 52117,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Megalocornea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The child in the picture has large corneas, photophobia, and lacrimation. What is the likely diagnosis? (</span>AIIMS May 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_xZp1Uzt.jpg\" alt=\"\" width=\"400\" height=\"166\"></span></p>",
      "unique_key": "Q3127013",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609710,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Congenital glaucoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_uXBfm5X.jpg\" alt=\"\" width=\"700\" height=\"264\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The clinical history of inability to open eyes in light (photophobia), excessive watering, and hazy cornea, along with the image suggests a diagnosis of congenital glaucoma.</span></li><li><span style=\"font-size:12.0pt;\">Primary congenital glaucoma is abnormally high intraocular pressure due to a developmental anomaly of the anterior chamber angle.</span></li><li><span style=\"font-size:12.0pt;\">Classification:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>True congenital glaucoma:</strong> IOP raised at birth.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Infantile glaucoma:</strong> Disease manifests before 3 years of age.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Juvenile glaucoma:</strong> IOP rises between 3-16 years of age.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">CYP1B1 gene is implicated in the pathogenesis.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-153026.png\" alt=\"\" width=\"500\" height=\"476\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Diagnostic features:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Corneal haze</strong> due to diffuse edema from elevated IOP</span></li><li><span style=\"font-size:12.0pt;\"><strong>Buphthalmos</strong> from stretching before the age of 3 years</span></li><li><span style=\"font-size:12.0pt;\"><strong>Haab striae&nbsp;</strong>and <strong>corneal</strong> <strong>scarring</strong> can occur.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Evaluation:</span><ul><li><span style=\"font-size:12.0pt;\">IOP measurement</span></li><li><span style=\"font-size:12.0pt;\">Corneal diameter measurement</span></li><li><span style=\"font-size:12.0pt;\">Gonioscopy</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmoscopy</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Management&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Surgical with goniotomy or trabeculotomy</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Goniotomy</strong>: to remove obstructed tissue in the eye's drainage system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Trabeculotomy</strong>: creates a drainage opening in the eye's trabecular meshwork.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">If unsuccessful: trabeculectomy, tube shunt implantation, and ciliary body ablative procedures are performed.</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Trabeculectomy</strong>: creates a new drainage channel for aqueous humor.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tube shunt implantation</strong>: involves placing a small tube in the eye to drain excess fluid.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ciliary body ablative procedures</strong>: destroy the ciliary body to reduce the production of aqueous humor.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Retinoblastoma:</strong> A cancer that would show more than simple enlargement of the corneas, typically presenting with a white pupillary reflex (leukocoria).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital hereditary endothelial dystrophy:</strong> Primarily affects the endothelium of the cornea, not associated with the enlargement of the corneas or elevated IOP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Megalocornea:</strong> A non-glaucomatous condition where the corneas are enlarged but without other symptoms like photophobia or increased IOP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Congenital glaucoma is characterized by symptoms like enlarged corneas, photophobia, and excessive lacrimation due to elevated intraocular pressure from developmental anomalies in the anterior chamber angle. Early diagnosis and management are crucial to prevent permanent vision loss.</span></p>",
      "correct_choice_id": 52114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3499,
      "choices": [
        {
          "id": 13975,
          "text": "<p><span style=\"font-size:12.0pt;\">Transmitted by chiggers</span></p>"
        },
        {
          "id": 13976,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphadenopathy is a feature</span></p>"
        },
        {
          "id": 13977,
          "text": "<p><span style=\"font-size:12.0pt;\">Produces NLF producing colonies in MacConkey agar</span></p>"
        },
        {
          "id": 13978,
          "text": "<p><span style=\"font-size:12.0pt;\">Man is an accidental host</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following is true regarding scrub typhus except:</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p>",
      "unique_key": "Q4725134",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Produces NLF producing colonies in MacConkey agar</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism – Orientia tsutsugamushi (an obligate intracellular Gram-negative bacterium).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>They cannot grow on cell free media</strong>. They are readily cultivated in yolk sac of developing chick embryos. They also grow on mouse fibroblast, HeLa, Hep-2, Detroit 6 and other continuous cell lines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vector - Infected chiggers (trombiculid mite larvae).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Host: A number of small rodents particularly wild rats&nbsp;</strong>of subgenus Rattus are the natural hosts for scrub typhus. <strong>Human infection takes place when man accidentally picks up an infective larval mite while walking, sitting, or lying on the infested ground.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The adult mites have a four-stage lifecycle: egg, larva, nymph and adult.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The larva is the only stage (chigger) that can transmit the disease to humans and other vertebrates,</strong> since the other life stages (nymph and adult) do not feed on vertebrate animals. Both the nymph and the adult are free-living in the soil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Signs and Symptoms- <u>Fever and chills, Headache, Body aches and muscle pain</u>. Dark, scab-like region at the site of the chigger bite (also known as <strong>eschar</strong>). Mental changes, ranging from <u>confusion to coma</u>. <u>Enlarged lymph nodes and rash</u> are also seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis of scrub typhus</strong> that includes enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), immunochromatographic test (ICT), Weil–Felix, polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Transmitted by chiggers</strong>: This is true. Scrub typhus is transmitted by the larvae (chiggers) of trombiculid mites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lymphadenopathy is a feature</strong>: This is true. Enlarged lymph nodes (lymphadenopathy) are a common feature of scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Man is an accidental host</strong>: This is true. Humans are accidental hosts who become infected when they come into contact with infected chiggers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi, the causative agent of scrub typhus, is an obligate intracellular bacterium that cannot grow on cell-free media like MacConkey agar. It requires living cells for its cultivation. Scrub typhus is transmitted by chiggers and features symptoms such as fever, lymphadenopathy, and a characteristic eschar at the site of the bite. Humans are accidental hosts for this infection.</span></p>",
      "correct_choice_id": 13977,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61199,
      "choices": [
        {
          "id": 244077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women aged 25 to 65 years</span></span></span></p>"
        },
        {
          "id": 244078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women aged 21 to 45 years</span></span></span></p>"
        },
        {
          "id": 244079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women aged 30 to 60 years</span></span></span></p>"
        },
        {
          "id": 244080,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women aged 40 to 75 years</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman visits her gynecologist for a routine check-up. She has been generally healthy, is sexually active, and has no significant medical history. She has never been diagnosed with any form of cancer and has no family history of cervical or other gynecological cancers. During the consultation, she asks about the necessity of cervical cancer screening, as she has not undergone any tests in the past five years. The physician emphasizes on the importance of regular screening for cervical cancer to prevent serious outcomes. Based on the latest guidelines, which group of individuals should be screened for cervical cancer?</span></span></span></p>",
      "unique_key": "Q7224829",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609712,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: A. Women aged 25 to 65 years</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to the American College of Obstetricians and Gynecologists (ACOG) and the American Cancer Society (ACS) guidelines (2020), cervical cancer screening is recommended for women aged 25 to 65 years. Screening should begin at age 25, with the preferred method being HPV testing every 5 years. Alternatively, HPV/Pap co-testing every 5 years or a Pap test alone every 3 years is acceptable. After the age of 65, screening can be stopped if there have been previous normal test results. The World Health Organization (WHO) guidelines (2020) recommend starting screening at age 30, primarily using HPV testing every 5 to 10 years. These guidelines are designed to detect pre-cancerous changes early and reduce the risk of developing cervical cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical cancer screening is recommended for women aged 25 to 65 years, with HPV testing every 5 years as the preferred method. Screening helps detect pre-cancerous changes and significantly reduces the risk of cervical cancer, emphasizing the importance of adhering to current guidelines for early detection and management.</span></span></span></p>",
      "correct_choice_id": 244077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6124,
      "choices": [
        {
          "id": 24465,
          "text": "<p><span style=\"font-size:12.0pt;\">Pathological doubt</span></p>"
        },
        {
          "id": 24466,
          "text": "<p><span style=\"font-size:12.0pt;\">Magical thinking</span></p>"
        },
        {
          "id": 24467,
          "text": "<p><span style=\"font-size:12.0pt;\">Hoarding</span></p>"
        },
        {
          "id": 24468,
          "text": "<p><span style=\"font-size:12.0pt;\">Contamination obsession</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has a poor prognosis with exposure and response prevention in OCD?&nbsp;</span>( NEET PG 2019)</p>",
      "unique_key": "Q6394692",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hoarding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among the OCD subtypes, hoarding has shown to be more resistant to treatment with ERP. This might be because individuals with hoarding disorder often do not recognize their behavior as problematic and may lack insight into the disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exposure and response prevention (ERP) is a type of cognitive-behavioral therapy that is effective for many individuals with obsessive-compulsive disorder (OCD). However, certain subtypes or themes of OCD might respond less effectively to ERP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pathological doubt:</strong> While challenging, ERP can be tailored to address pathological doubt by creating exposures that trigger doubt without seeking reassurance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Magical thinking:</strong> ERP can also be adapted for magical thinking by exposing the individual to the feared situation or thought without engaging in the ritualistic behavior.</span></p><p>&nbsp;</p><p><strong>Option&nbsp;</strong><span style=\"font-size:12.0pt;\"><strong>D. Contamination obsession:</strong> Contamination fears are typically one of the subtypes that respond quite well to ERP, as the therapist can create direct exposures involving the feared contaminant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hoarding disorder is characterised by acquiring and not being able to discard things that are considered to have little or no use. This will lead to cluttering of house, to an extent that it becomes unsafe to live. This disorder is driven by fear of losing something important. Treatment includes SSRIs and CBT.&nbsp; Hoarding disorder tends to have a <strong>poorer prognosis with exposure and response prevention compared to other subtypes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 431.</strong></span></p>",
      "correct_choice_id": 24467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14353,
      "choices": [
        {
          "id": 57373,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpable abdominal lump is the earliest sign</span></p>"
        },
        {
          "id": 57374,
          "text": "<p><span style=\"font-size:12.0pt;\">Earliest sign is jaundice</span></p>"
        },
        {
          "id": 57375,
          "text": "<p><span style=\"font-size:12.0pt;\">Clinical presentation of gall stones can&nbsp;sometimes&nbsp;be distinguished from gall bladder cancer</span></p>"
        },
        {
          "id": 57376,
          "text": "<p><span style=\"font-size:12.0pt;\">Median age of survival is 6 months in all cases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old woman presents to the hospital with right upper quadrant pain, nausea, vomiting, and anorexia. She was diagnosed with cholecystitis and cholelithiasis and underwent cholecystectomy. The post-operative biopsy reports came back positive for gallbladder carcinoma. What is true about gallbladder carcinoma?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q1491135",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Clinical presentation of gall stones can sometimes be distinguished from gall bladder cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is correct. The clinical presentation of gallstones (cholelithiasis) and gallbladder cancer (carcinoma) can sometimes be distinguished. Gallstones commonly cause symptoms such as biliary colic (episodic, severe right upper quadrant pain) and may lead to acute cholecystitis, which includes symptoms like pain, fever, nausea, and vomiting. In contrast, gallbladder carcinoma may present with more persistent or progressive symptoms, including unexplained weight loss and, in some cases, a palpable abdominal mass. The two conditions can have overlapping symptoms, but their clinical courses can be distinguished based on the duration and progression of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Palpable abdominal lump is the earliest sign</strong>: This statement is not true. A palpable abdominal lump is not typically the earliest sign of gallbladder carcinoma. Gallbladder carcinoma often presents with nonspecific symptoms such as right upper quadrant pain, nausea, vomiting, and anorexia. As the cancer progresses, it may cause other symptoms, but a palpable lump is usually a late finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Earliest sign is jaundice</strong>: This statement is also not true for most cases of gallbladder carcinoma. Jaundice is more commonly associated with cancers of the bile ducts (cholangiocarcinoma) or pancreatic cancer when the tumor obstructs the bile ducts. While gallbladder carcinoma can cause jaundice if it obstructs the common bile duct, it is not typically the earliest sign of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Median age of survival is 6 months</strong>: This statement is not accurate for all cases of gallbladder carcinoma. The survival rate for gallbladder carcinoma can vary widely depending on factors such as the stage at diagnosis and the extent of surgical resection. While some cases have a poor prognosis with a short median survival, others may have a better outcome if diagnosed at an earlier stage and treated appropriately.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Option C is correct because gallstones and gallbladder carcinoma often have distinct clinical presentations, allowing them to be distinguished from each other.</span></p>",
      "correct_choice_id": 57375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11138,
      "choices": [
        {
          "id": 44518,
          "text": "<p><span style=\"font-size:18px;\">Mean = mode = median</span></p>"
        },
        {
          "id": 44519,
          "text": "<p><span style=\"font-size:18px;\">Mean = median, not equal to mode</span></p>"
        },
        {
          "id": 44520,
          "text": "<p><span style=\"font-size:18px;\">Mean, median, mode not equal</span></p>"
        },
        {
          "id": 44521,
          "text": "<p><span style=\"font-size:18px;\">Mode = median, not equal to mean</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>The image shows two data distribution curves from separate studies within the same population: one depicted with a red line and the other with a blue line. Given the graphical representation, which of the following correctly represents the relationship among the mean, median, and mode for the data presented? </strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip39.jpg\" alt=\"\" width=\"300\" height=\"223\"></strong></span></p>",
      "unique_key": "Q4589721",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609715,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Mean = median, not equal to mode</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Analyzing the two graphs, we observe different distribution patterns:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Red line (Study A):</strong> The distribution is unimodal and symmetrical, indicating that the mean, median, and mode are all equal.</span></li><li><span style=\"font-size:18px;\"><strong>Blue line (Study B):</strong> The distribution is bimodal, showing two distinct peaks. In a bimodal distribution, the mean and median are typically equal, but there are two modes, making the mode not equal to the mean or median.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a bimodal distribution, the mean and median can be equal, but the mode will not be equal to them, as there are two modes.</span></p>",
      "correct_choice_id": 44519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7178,
      "choices": [
        {
          "id": 28680,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Midazolam</span></span></span></p>"
        },
        {
          "id": 28681,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diazepam</span></span></span></p>"
        },
        {
          "id": 28682,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alprazolam</span></span></span></p>"
        },
        {
          "id": 28683,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxazepam</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is brought with altered sensorium and seizures. Attendant shows the laboratory report which reveals elevated transaminases. Which of the following can be used in this condition? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q5989054",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609716,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Oxazepam</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxazepam is a short acting Benzodiazepine, which has no active metabolites and can be used safely in a patient with active liver disease. Other BZDs that can be used include Temazepam, Lorazepam, Estazolam.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Midazolam</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Midazolam is metabolized in the liver through oxidative pathways and produces active metabolites. It is not the best choice for patients with liver impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Diazepam</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Diazepam is metabolized in the liver to active metabolites, which can accumulate in patients with liver dysfunction, potentially leading to prolonged sedation and toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Alprazolam</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Alprazolam is also metabolized in the liver through oxidative processes and has active metabolites. It is not recommended for patients with significant liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with liver impairment, such as those with elevated transaminases, it is crucial to use medications that are not heavily reliant on hepatic metabolism and do not produce active metabolites. Oxazepam, being metabolized via conjugation, is a safer option in such scenarios compared to other benzodiazepines like midazolam, diazepam, and alprazolam.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember with mnemonic &lsquo;<span style=\"color:red\">STOLE&rsquo;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:red\">S</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hort-acting Benzodiazepines</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:red\">T</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">emazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:red\">O</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">xazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:red\">L</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:red\">E</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">stazolam</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 28683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6517,
      "choices": [
        {
          "id": 26037,
          "text": "<p><span style=\"font-size:12.0pt;\">Naproxen</span></p>"
        },
        {
          "id": 26038,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 26039,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 26040,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with chronic kidney disease underwent nephrectomy. Which of the following can be administered as a postoperative analgesic in this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q3841196",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609717,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Acetaminophen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with chronic kidney disease (CKD), nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen, indomethacin, and diclofenac are generally avoided due to their potential to worsen renal function. These medications inhibit prostaglandin synthesis, which can lead to renal vasoconstriction and further decline in kidney function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen (paracetamol), on the other hand, is generally considered safer for patients with CKD when used at appropriate doses. It has a different mechanism of action (inhibit COX3) and does not significantly affect renal hemodynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Naproxen: </strong>Naproxen is an NSAID that can significantly impair renal function, especially in patients with pre-existing kidney disease. It should be avoided in this population due to the risk of worsening kidney function and potential for causing renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Indomethacin: </strong>Indomethacin is another NSAID with similar risks to naproxen. Its use can lead to decreased renal perfusion and exacerbate renal impairment, making it unsuitable for patients with CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diclofenac: </strong>Diclofenac, like other NSAIDs, poses a significant risk to kidney function in patients with CKD. It can reduce prostaglandin synthesis, leading to renal vasoconstriction and further renal impairment, and should be avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen is the preferred postoperative analgesic for patients with chronic kidney disease, as it does not significantly affect renal function and is safer than NSAIDs in this population.</span></p>",
      "correct_choice_id": 26040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9940,
      "choices": [
        {
          "id": 39726,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 39727,
          "text": "<p><span style=\"font-size:12.0pt;\">Leprosy</span></p>"
        },
        {
          "id": 39728,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 39729,
          "text": "<p><span style=\"font-size:12.0pt;\">Visceral leishmaniasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the given condition:</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture24.jpg\" alt=\"\" width=\"300\" height=\"211\"></p>",
      "unique_key": "Q5036860",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609718,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given histology image shows a suprabasal blister which points to a diagnosis of Pemphigus Vulgaris.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-182933.jpg\" alt=\"\" width=\"995\" height=\"979\"></span></p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-183030.jpg\" alt=\"\" width=\"1000\" height=\"691\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Leprosy</strong>: Tuberculoid leprosy (paucibacillary) will show granulomatous lesions while lepromatous lesions (multibacillary) shows lipid-laden macrophages (lepra cells) filled with masses (globi) of acid-fast bacilli.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture25.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycosis fungoides</strong>: Lower portion of the epidermis contains hyperchromatic enlarged lymphocytes. Pautrier’s microabscesses may be seen which are intradermal clusters of atypical lymphoid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture26.jpg\" alt=\"\" width=\"300\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Visceral Leishmaniasis</strong>: Visceral Leishmaniasis shows skin lesion with abundant amastigotes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture27.jpg\" alt=\"\" width=\"300\" height=\"239\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris is characterized by suprabasal blisters and a row of tombstone appearance on histology, with a fishnet pattern on direct immunofluorescence due to IgG deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and cotran pathologic basis of disease 8<sup>th</sup> edition 2307-2308</strong></span></p>",
      "correct_choice_id": 39726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11073,
      "choices": [
        {
          "id": 44258,
          "text": "<p><span style=\"font-size:18px;\">100</span></p>"
        },
        {
          "id": 44259,
          "text": "<p><span style=\"font-size:18px;\">10</span></p>"
        },
        {
          "id": 44260,
          "text": "<p><span style=\"font-size:18px;\">250</span></p>"
        },
        {
          "id": 44261,
          "text": "<p><span style=\"font-size:18px;\">160</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A drug trial was initiated under Medicine department to test the efficacy of a new medication in comparison to a placebo. The participants were divided into two cohorts. Cohort A received a placebo, while cohort B was treated with the novel drug. Out of the 120 participants in cohort A, 36 faced fatal outcomes. In cohort B, with 130 participants, there were 26 fatal outcomes. Given this data, if a clinician were to incorporate this novel medication into practice, how many patients would they need to treat with this new medication to prevent one additional fatality when compared to the placebo group? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
      "unique_key": "Q2312613",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609719,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 10</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">10 patients need to be treated with the new drug to avert 1 death.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">We can group divide the case scenario into two groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Experimental (New treatment) group – 26 Treatment failures out of 130</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Control (Old treatment) group – 36 Treatment failures out of 120</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124705.jpg\" alt=\"\" width=\"700\" height=\"184\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Now, we have to calculate failure rate in both groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Experimental (New treatment) group – 26/130 = 0.2</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Control (Old treatment) group – 36/120 = 0.3</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">&nbsp;<strong>Absolute risk reduction (ARR) </strong>is the difference of failure in both groups = 0.3 – 0.2 = 0.1</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Number needed to treat (NNT) = 1/ARR </strong>= 1/0.1 = 10</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Number Needed to Treat (NNT) is a practical measure used in decision-making for clinical interventions.</span></li><li><span style=\"font-size:18px;\">It represents the number of patients that need to be treated with a particular therapy over a specific period to prevent one additional bad outcome, such as death in this scenario.</span></li><li><span style=\"font-size:18px;\">An NNT of 10 indicates that the new medication has a significant impact in reducing fatalities compared to the placebo.</span></li></ul>",
      "correct_choice_id": 44259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5989,
      "choices": [
        {
          "id": 23926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10%</span></span></span></p>"
        },
        {
          "id": 23927,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4%</span></span></span></p>"
        },
        {
          "id": 23928,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6%</span></span></span></p>"
        },
        {
          "id": 23929,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8%</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What should be the ideal percentage for normal sperm morphology in a seminal fluid analysis?</span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5058093",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609720,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 4%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphology is the most important factor/marker of semen analysis. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per the strict criteria, &gt;4% normal forms of morphology must be present.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-280.jpg\" style=\"height:307px; width:900px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal percentage for normal sperm morphology in a seminal fluid analysis is &gt;4% according to WHO 2010 criteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of gynecology 3rd edition Pg442, Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg232</span></strong></span></span></p>",
      "correct_choice_id": 23927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6979,
      "choices": [
        {
          "id": 27884,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1 B-2 C-3</span></span></span></p>"
        },
        {
          "id": 27885,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2 B-1 C-3</span></span></span></p>"
        },
        {
          "id": 27886,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3 B-2 C-1</span></span></span></p>"
        },
        {
          "id": 27887,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1 B-3 C-2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following dilution of adrenaline and its use? (</span></span>INICET Nov 2020)</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154726.jpg\" style=\"height:239px; width:700px\" /></p>",
      "unique_key": "Q4982983",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609721,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. A-2 B-1 C-3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilutions of adrenaline (epinephrine) with their typical uses:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1:1000&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">dilution of adrenaline is more concentrated and is commonly used in the treatment of <strong>Anaphylaxis</strong>. It is administered intramuscularly in emergency situations for its rapid vasoconstrictive and bronchodilating effects.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1:10000&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dilution is less concentrated and is typically used in the management of <strong>Cardiac Arrest</strong>. It&#39;s administered intravenously.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1:100000&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dilution is used as an additive in <strong>Local Anesthesia</strong>. The vasoconstrictive properties of adrenaline help to prolong the action of the local anesthetic and reduce bleeding in the surgical field.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154955.jpg\" style=\"height:487px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 27885,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10391,
      "choices": [
        {
          "id": 41530,
          "text": "<p><span style=\"font-size:12.0pt;\">Colloid carcinoma</span></p>"
        },
        {
          "id": 41531,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary carcinoma</span></p>"
        },
        {
          "id": 41532,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma</span></p>"
        },
        {
          "id": 41533,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobular carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old woman presents with a lump in the upper outer quadrant of her breast. Histopathological examination of the mass showed cells in mucin pools and faint nuclei. What is the most likely diagnosis? (NEET PG 2020)</span></p>",
      "unique_key": "Q9915251",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609722,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Colloid carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given scenario is suggestive of colloid or mucinous carcinoma of the breast.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a rare type of breast cancer that occurs more frequently in older women and grows slowly. The prognosis of colloid carcinoma is better than that of infiltrating duct carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tumor is typically a soft, gelatinous mass with well-defined borders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histologically, colloid carcinoma has <strong>a lot of extracellular epithelial mucin and mucin-filled acini</strong>. Floating in large lakes of mucin are cuboidal to tall columnar tumor cells, some of which show mucus vacuolation. Nuclei in intracellular type are pushed to the periphery, forming a signet ring appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papillary carcinoma:&nbsp;</strong>Papillary carcinoma of the breast is characterized by the presence of papillary structures lined by neoplastic cells.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It does not typically present with large pools of mucin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Medullary carcinoma:&nbsp;</strong>Medullary carcinoma is characterized by large, high-grade cells with a syncytial growth pattern, prominent lymphoplasmacytic infiltrate, and pushing borders.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It lacks the extensive mucin pools seen in colloid carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lobular carcinoma:&nbsp;</strong>Lobular carcinoma is characterized by small, uniform cells arranged in single-file lines or targetoid patterns.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It typically lacks the mucin pools characteristic of colloid carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Colloid carcinoma of the breast, also known as mucinous carcinoma, is identified by the presence of tumor cells floating in large extracellular mucin pools. This rare type of breast cancer has a better prognosis compared to infiltrating duct carcinoma and is characterized histologically by its mucinous components.</span></p>",
      "correct_choice_id": 41530,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61198,
      "choices": [
        {
          "id": 244073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Formalin</span></span></span></p>"
        },
        {
          "id": 244074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">95% Ethyl Alcohol</span></span></span></p>"
        },
        {
          "id": 244075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acetic Acid Solution</span></span></span></p>"
        },
        {
          "id": 244076,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methanol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 42-year-old woman comes to your office for her annual gynecological examination. She has no significant medical history, is a non-smoker, and has been compliant with her routine screenings. During the exam, a Pap smear is performed to screen for cervical cancer, and the clinician emphasizes the importance of immediate fixation of the sample to preserve cellular morphology for accurate evaluation. What is the most appropriate fixative used for preserving the Pap smear sample in this scenario?</span></span></span></p>",
      "unique_key": "Q3638374",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609723,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. 95% Ethyl Alcohol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The standard fixative for Pap smears is 95% ethyl alcohol, which effectively preserves the cellular details necessary for cytological evaluation by preventing autolysis and degradation of the cells. This fixative ensures that the morphology of the cells is maintained, which is critical for identifying any cellular abnormalities such as dysplasia or carcinoma. Proper fixation allows for an accurate interpretation of the smear, which is essential in cervical cancer screening. Modern practice also employs ethanol sprays, which offer a convenient alternative for immediate fixation in clinical settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Formalin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Formalin is commonly used in histopathology to fix tissue samples but is unsuitable for Pap smears as it can cause cellular shrinkage and artifacts that hinder cytological evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> C. Acetic Acid Solution:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Acetic acid is primarily used to enhance the visibility of cellular abnormalities during colposcopy but does not preserve cellular structure and morphology, making it inappropriate as a Pap smear fixative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> D. Methanol:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Methanol can serve as a fixative, but it is less commonly used compared to 95% ethyl alcohol due to its lower effectiveness in preserving the fine details of cellular morphology necessary for accurate Pap smear evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">95% Ethyl alcohol is the most commonly used fixative for Pap smears, crucial for preserving cellular morphology and preventing degradation, allowing for accurate cytological assessment and early detection of cervical abnormalities</span></span></span></p>",
      "correct_choice_id": 244074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44828,
      "choices": [
        {
          "id": 178959,
          "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
        },
        {
          "id": 178960,
          "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
        },
        {
          "id": 178961,
          "text": "<p><span style=\"font-size:12pt;\">Nitrous oxide</span></p>"
        },
        {
          "id": 178962,
          "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Inhalational anaesthetic agent of choice in children is</span>(INICET MAY 2024)</p>",
      "unique_key": "Q4227132",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609724,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sevoflurane</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sevoflurane is the inhalational anesthetic agent of choice in children. It has a rapid onset and offset, a pleasant smell, and causes minimal airway irritation, making it ideal for inhalational induction in pediatric patients. It also has a relatively low blood-gas partition coefficient, leading to quick recovery times.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Desflurane</strong>: Desflurane is another potent inhalational anesthetic with a very low blood-gas partition coefficient, resulting in rapid induction and emergence from anesthesia. However, it can cause airway irritation and coughing, making it less suitable for children, particularly for inhalational induction.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Nitrous oxide</strong>: Nitrous oxide is commonly used as an adjunct to other anesthetic agents due to its analgesic properties and rapid onset. However, it is not used as the sole agent for induction of anesthesia because it is not potent enough to achieve surgical anesthesia on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Isoflurane</strong>: Isoflurane is a potent inhalational anesthetic but has a pungent odor and can cause airway irritation. It is less commonly used for inhalational induction in children due to these properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sevoflurane is preferred for pediatric anesthesia due to its favorable profile, including rapid onset and recovery, minimal airway irritation, and a pleasant smell, making it well-tolerated by children.</span></p>",
      "correct_choice_id": 178959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24776,
      "choices": [
        {
          "id": 99065,
          "text": "<p><span style=\"font-size:11.0pt;\">Left motor cortex</span></p>"
        },
        {
          "id": 99066,
          "text": "<p><span style=\"font-size:11.0pt;\">Right motor cortex</span></p>"
        },
        {
          "id": 99067,
          "text": "<p><span style=\"font-size:11.0pt;\">Left posterior parietal area</span></p>"
        },
        {
          "id": 99068,
          "text": "<p><span style=\"font-size:11.0pt;\">Right posterior parietal area</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A person comes to the OPD with symptoms of not using his left side and not washing the left side of his body while bathing. On examination he wasn't able to draw the left side of the images. Which of the following is the most likely location of the lesion? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152753.png\" alt=\"\" width=\"300\" height=\"293\"></span></p>",
      "unique_key": "Q6628804",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609725,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Right posterior parietal area</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms described indicate left-sided hemi-neglect, which is typically due to a lesion in the non-dominant (right) posterior parietal area, responsible for spatial awareness and attention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Left motor cortex:</strong> Would result in right-sided motor deficits.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Right motor cortex:</strong> Would result in left-sided motor deficits but not neglect.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Left posterior parietal area:</strong> Would result in right-sided hemi-neglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Left-sided neglect is often due to a lesion in the right posterior parietal area.</span></p>",
      "correct_choice_id": 99068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3399,
      "choices": [
        {
          "id": 13575,
          "text": "<p><span style=\"font-size:12.0pt;\">Human Immunodeficiency Virus (HIV)</span></p>"
        },
        {
          "id": 13576,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis A Virus (HAV)</span></p>"
        },
        {
          "id": 13577,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B Virus (HBV)</span></p>"
        },
        {
          "id": 13578,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis C Virus (HCV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Solvent/Detergent (SD) plasma destroys lipid-enveloped viruses. So, on SD plasma transfusion, which of the following infection is likely to occur? (INICET MAY 2018)</span></p>",
      "unique_key": "Q4885592",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609726,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hepatitis A Virus (HAV)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The solvent/detergent (SD) process used for plasma can safely inactivate all lipid-enveloped virus. <strong>HAV is a non-enveloped virus,</strong> and hence it's not affected by solvent/detergent (SD) plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hepatitis B, C, and HIV are enveloped.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Human Immunodeficiency Virus (HIV):</strong> HIV is an enveloped virus. The SD process effectively inactivates HIV by disrupting its lipid envelope, making it non-infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepatitis B Virus (HBV):</strong> HBV is also an enveloped virus. The SD process disrupts the lipid envelope of HBV, rendering it non-infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hepatitis C Virus (HCV):</strong> HCV is another enveloped virus. The SD process targets and inactivates HCV by disrupting its lipid envelope.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The solvent/detergent (SD) process inactivates lipid-enveloped viruses such as HIV, HBV, and HCV. However, it does not inactivate non-enveloped viruses like Hepatitis A Virus (HAV), making HAV infections a potential risk during SD plasma transfusion.</span></p>",
      "correct_choice_id": 13576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43911,
      "choices": [
        {
          "id": 175307,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATM</span></span></span></span></p>"
        },
        {
          "id": 175308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 1</span></span></span></span></p>"
        },
        {
          "id": 175309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MSH 2</span></span></span></span></p>"
        },
        {
          "id": 175310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ku 70</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one is not helpful in DNA Double stand break repair?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2023)</span></span></p>",
      "unique_key": "Q9025800",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609727,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) MSH 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MSH 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is part of the mismatch repair (MMR) system and does not play a direct role in repairing double-strand breaks (DSBs) in DNA. Its main function is to correct base-pair mismatches and insertion-deletion loops during DNA replication and recombination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. ATM:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ataxia telangiectasia mutated (ATM) protein is crucial for recognizing DNA double-strand breaks and initiating repair via the homologous recombination pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. BRCA 1:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breast cancer type 1 susceptibility protein is involved in the repair of DNA double-strand breaks predominantly through the homologous recombination pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ku 70:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ku 70, along with Ku 80, forms the Ku heterodimer, which binds to DNA double-strand breaks and plays a critical role in the non-homologous end joining (NHEJ) repair pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MSH 2 is associated with mismatch repair and not directly involved in the repair mechanisms of double-strand breaks, which are crucial processes for maintaining genomic stability and preventing malignant transformations</span></span></span></p>",
      "correct_choice_id": 175309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5886,
      "choices": [
        {
          "id": 23514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a screening test for cervical cancer</span></span></span></p>"
        },
        {
          "id": 23515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a diagnostic test for trichomonas infection</span></span></span></p>"
        },
        {
          "id": 23516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to diagnose cancer in her genital tract</span></span></span></p>"
        },
        {
          "id": 23517,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to diagnose other associated genital infections in her</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient comes with repeated infections of trichomonas vaginitis; her physician advises for a Pap smear. She asks you regarding the purpose of this test. What would be your appropriate response?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q2687156",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609728,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It is a screening test for cervical cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear is a screening test for cervical cancer.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cervical smear is prepared using the pap test which is sent for cytological examination</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of malignant cells on Pap smear requires further evaluation with colposcopy, cervical biopsy, fractional curettage, etc.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prerequisites:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should be done prior to vaginal examination</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lubricants should not be used</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient should not be menstruating during the pap test</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal time is around ovulation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient should not have intercourse 24hrs prior to the test</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is a diagnostic test for trichomonas vaginalis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Trichomonas vaginalis is diagnosed by seeing the flagellated organism (T. vaginalis) on a vaginal smear</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It helps to diagnose cervical cancer in her genital tract</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A pap smear is specifically for cervical cancer screening and also for recurrence from the vaginal vault following hysterectomy for CIN/ cervical cancer. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It helps to diagnose other associated genital infections in her:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A pap smear can detect associated genital infections especially cervical infections but is not routinely used for this purpose</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Pap smear is a screening test for cervical cancer, used to identify abnormal cells in the cervix.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 113, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition.</span></strong></span></span></p>",
      "correct_choice_id": 23514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14435,
      "choices": [
        {
          "id": 57701,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of upper and middle third of the sternomastoid muscle</span></p>"
        },
        {
          "id": 57702,
          "text": "<p><span style=\"font-size:12.0pt;\">Junction of middle and lower third of the sternomastoid muscle</span></p>"
        },
        {
          "id": 57703,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle of the sternomastoid muscle</span></p>"
        },
        {
          "id": 57704,
          "text": "<p><span style=\"font-size:12.0pt;\">Between the two heads of the sternomastoid muscle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of these is the most common site of a branchial cyst? (</span>NEET PG 2019)</p>",
      "unique_key": "Q5308331",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609729,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Junction of upper and middle third of the sternomastoid muscle</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The typical location for a branchial cyst is at the anterior border of the junction between the upper and middle third of the sternomastoid muscle. Branchial cysts are developmental anomalies that arise from the remnants of the second branchial cleft. They are lined by squamous epithelium and contain thick, cloudy fluid that often includes cholesterol crystals. This location is key for identifying and diagnosing branchial cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Junction of middle and lower third of the sternomastoid muscle:&nbsp;</strong>This location is typically associated with the external opening of a branchial fistula, not a branchial cyst.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Middle of the sternomastoid muscle:&nbsp;</strong>This is not the usual site for branchial cysts. Branchial cysts are more commonly found at the anterior border of the upper and middle third junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Between the two heads of the sternomastoid muscle:&nbsp;</strong>This area is not associated with the typical location of branchial cysts. The cysts are more commonly found anterior to the sternomastoid muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Information on Branchial Cysts:</strong></span></p><ul><li><span style=\"font-size:12pt;\"><strong>Origin</strong>: Congenital or acquired remnants of the second branchial cleft.</span></li><li><span style=\"font-size:12pt;\"><strong>Lining</strong>: Squamous epithelium.</span></li><li><span style=\"font-size:12pt;\"><strong>Contents</strong>: Thick, cloudy fluid with cholesterol crystals, sometimes clear fluid making the cyst soft and shiny.</span></li><li><span style=\"font-size:12pt;\"><strong>Branchial Fistula</strong>: The external opening of a branchial fistula is at the junction of the middle and lower third of the anterior border of the sternocleidomastoid.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common site for a branchial cyst is at the anterior border of the junction between the upper and middle third of the sternomastoid muscle.</span></p>",
      "correct_choice_id": 57701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15155,
      "choices": [
        {
          "id": 60580,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 60581,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        },
        {
          "id": 60582,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 60583,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are a part of the limbic system?(INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Amygdala</span></p><p><span style=\"font-size:12.0pt;\">2. Hippocampus</span></p><p><span style=\"font-size:12.0pt;\">3. Thalamus</span></p><p>&nbsp;</p>",
      "unique_key": "Q1009485",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The limbic system is a complex set of brain structures located on both sides of the thalamus, immediately beneath the cerebrum. It includes key components such as the amygdala, hippocampus, thalamus, hypothalamus, basal ganglia, and cingulate gyrus. These structures support a variety of functions related to emotions, behavior, motivation, long-term memory, and olfaction.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Amygdala:</strong> Integral for processing emotions, the amygdala is especially involved in fear, anxiety, and social cognition. It also plays a significant role in forming and retrieving emotional memories.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hippocampus:</strong> Essential for learning and memory, the hippocampus is pivotal in the consolidation of information from short-term memory to long-term memory and spatial navigation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thalamus:</strong> Although primarily known as the relay station for sensory and motor signals to the cerebral cortex, the thalamus also supports functions of the limbic system by regulating consciousness, sleep, and alertness.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other structures are :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hypothalamus is involved in regulating many bodily functions, including hunger, thirst, body temperature, and circadian rhythms. It also plays a key role in the regulation of the autonomic nervous system and the endocrine system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cingulate gyrus is involved in a variety of functions, including emotion regulation, attention, and the processing of pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Together, these structures form a complex network that plays a crucial role in many aspects of human behavior and cognition. Dysfunction or damage to the limbic system can lead to a range of neurological and psychiatric disorders, including Alzheimer's disease, depression, anxiety, and post-traumatic stress disorder (PTSD).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/anatomy-may-inicet-2022-19-1.jpg\" alt=\"\" width=\"500\" height=\"301\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The limbic system’s role is critical, as its structures are deeply integrated into the processes governing emotions, memory, and essential physiological functions. Damage or dysfunction in any part of the limbic system can lead to profound psychological and cognitive impairments, affecting everything from emotional regulation to memory processing.</span></p>",
      "correct_choice_id": 60583,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61197,
      "choices": [
        {
          "id": 244069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-androgens</span></span></span></p>"
        },
        {
          "id": 244070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadotropins</span></span></span></p>"
        },
        {
          "id": 244071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Letrozole</span></span></span></p>"
        },
        {
          "id": 244072,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamoxifen</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 29-year-old woman presents to the gynecology clinic with complaints of irregular menstrual cycles, hirsutism, and difficulty conceiving. She reports that her periods have been irregular since her teenage years, and she has gained weight in the past two years. Physical examination reveals central obesity and signs of androgen excess, such as increased facial hair and acne. An ultrasound confirms the presence of multiple ovarian follicles consistent with polycystic ovary syndrome (PCOS). The patient is interested in starting treatment to help regulate her cycles and improve her chances of conception. Which of the following is not typically used in the management of polycystic ovary syndrome (PCOS)?</span></span></span></p>",
      "unique_key": "Q2567085",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609731,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: D. Tamoxifen</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tamoxifen is not typically used in the management of polycystic ovary syndrome (PCOS). Tamoxifen is a selective estrogen receptor modulator primarily used in the treatment and prevention of breast cancer rather than managing symptoms of PCOS. It does not address key aspects of PCOS management such as ovulation induction, insulin resistance, or androgen suppression, which are essential in treating this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A. Anti-androgens</strong>: Anti-androgens, such as spironolactone and finasteride, are used in PCOS to manage symptoms of androgen excess, including hirsutism and acne. These medications help reduce hair growth and improve skin appearance but are not used when trying to conceive due to their anti-androgenic effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B. Gonadotropins</strong>: Gonadotropins, such as FSH and LH, are used in PCOS for ovulation induction, particularly when other treatments like clomiphene or letrozole have failed. They are administered under careful monitoring to stimulate the ovaries directly, aiding in fertility management for women with PCOS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. Letrozole</strong>: Letrozole is an aromatase inhibitor widely used as a first-line treatment for ovulation induction in women with PCOS. It works by lowering estrogen levels, leading to an increase in FSH release, which stimulates ovulation, making it particularly useful for women trying to conceive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PCOS management includes addressing hormonal imbalances, insulin resistance, and hyperandrogenism symptoms. Treatment options include anti-androgens for androgen excess, gonadotropins for ovarian stimulation in fertility treatment, and letrozole for ovulation induction. Tamoxifen is not used in PCOS management, as it does not target these essential aspects of the condition.</span></span></span></p>",
      "correct_choice_id": 244072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4175,
      "choices": [
        {
          "id": 16679,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia rickettsii</span></span></span></p>"
        },
        {
          "id": 16680,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia conorii</span></span></span></p>"
        },
        {
          "id": 16681,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ehrlichia chaffeensis</span></span></span></p>"
        },
        {
          "id": 16682,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaplasma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image of Rickettsial morula in a monocyte is shown below. Identify the organism? (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-102120.png\" style=\"height:211px; width:300px\" /></p>",
      "unique_key": "Q5783293",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Ehrlichia chaffeensis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is an obligate intracellular, Gram-negative species of Rickettsiales bacteria. It is a zoonotic pathogen transmitted to humans by the lone star tick (Amblyomma americanum) and is the causative agent of human monocytic ehrlichiosis (HME).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichiosis is evidenced by the presence of intracytoplasmic inclusions known as morulae in monocytes, which can be observed on a Giemsa-stained blood film.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Characteristics and Clinical Presentation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transmission:</span></strong><span style=\"font-size:12.0pt\"> By the lone star tick (Amblyomma americanum).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Symptoms:</span></strong><span style=\"font-size:12.0pt\"> Patients typically exhibit symptoms within 1 to 2 weeks after tick infection. Early symptoms include fever, headache, malaise, low-back pain, and gastrointestinal symptoms. Some patients may also have myalgias, arthralgias, coughing, pharyngitis, diarrhea, vomiting, abdominal pain, and changes in mental status.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis:</span></strong><span style=\"font-size:12.0pt\"> Besides observing morulae in monocytes, serological tests like indirect fluorescent antibody tests and polymerase chain reaction (PCR) are also used for diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Treatment:</span></strong><span style=\"font-size:12.0pt\"> TOC Doxycycline.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rickettsia rickettsii</span></strong><span style=\"font-size:12.0pt\">: <strong>Incorrect.</strong> Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever (RMSF), typically associated with rash and vascular endothelial damage, not morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Rickettsia conorii: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Rickettsia conorii causes Mediterranean spotted fever, which also does not present with morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anaplasma: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Anaplasma phagocytophilum causes human granulocytic anaplasmosis (HGA), where morulae are found in granulocytes, not monocytes. The presence of morulae in granulocytes is characteristic of Anaplasma infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is identified by the presence of morulae in monocytes and is the causative agent of human monocytic ehrlichiosis. The proper treatment is doxycycline, and diagnosis is confirmed through blood smear, serological tests, and PCR.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GAME &ndash; Granulocytes: Anaplasma; Monocytes: Ehrlichiosis</span></strong></span></span></p>",
      "correct_choice_id": 16681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32729,
      "choices": [
        {
          "id": 130766,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Pyridoxine </span></span></span></p>"
        },
        {
          "id": 130767,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">B<sub>1</sub></span></span></span></p>"
        },
        {
          "id": 130768,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">B<sub>3 </sub></span></span></span></p>"
        },
        {
          "id": 130769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">B<sub>12</sub>&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia can be treated by?</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q1333034",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609733,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans A) Pyridoxine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A. Pyridoxine: </strong>Pyridoxine, also known as vitamin B6, can be effective in treating certain forms of sideroblastic anemia, particularly those associated with a deficiency in pyridoxine-dependent enzymes. It helps improve heme synthesis and reduce the accumulation of iron in the mitochondria of red blood cell precursors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B1:</strong> Vitamin B1, also known as thiamine, is not typically used in the treatment of sideroblastic anemia. Thiamine deficiency can lead to other conditions, such as beriberi or Wernicke-Korsakoff syndrome, but it is not directly related to sideroblastic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B3: </strong>Vitamin B3, also known as niacin, is not typically used in the treatment of sideroblastic anemia. Niacin deficiency can lead to pellagra but is not directly associated with this type of anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. B12</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Vitamin B12, also known as cobalamin, is essential for the production of red blood cells and is used in the treatment of megaloblastic anemias, such as those caused by vitamin B12 deficiency or folate deficiency. It is not a primary treatment for sideroblastic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sideroblastic anemia can be treated with Pyridoxine (vitamin B6) supplementation, which helps improve heme synthesis and reduce iron accumulation in red blood cell precursors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref - Harper 31<sup>st</sup> e/p 310</span></span></strong></p>",
      "correct_choice_id": 130766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4222,
      "choices": [
        {
          "id": 16865,
          "text": "<p><span style=\"font-size:12.0pt;\">1 - 2 - 3 - 4 - 5</span></p>"
        },
        {
          "id": 16866,
          "text": "<p><span style=\"font-size:12.0pt;\">5 - 4 - 3 - 2 - 1</span></p>"
        },
        {
          "id": 16867,
          "text": "<p><span style=\"font-size:12.0pt;\">2 - 1 - 3 - 4 - 5</span></p>"
        },
        {
          "id": 16868,
          "text": "<p><span style=\"font-size:12.0pt;\">3 - 4 -5 - 1 - 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the following in the sequence of auditory pathway: (</span>INICET May 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Cochlear nucleus</span></li><li><span style=\"font-size:12.0pt;\">Spiral ganglion</span></li><li><span style=\"font-size:12.0pt;\">Superior olivary nucleus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li></ol>",
      "unique_key": "Q1024914",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609734,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2 -1 - 3 - 4- 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The auditory pathway begins at the peripheral sensory receptors and progresses through a series of nuclei and tracts in the central nervous system before reaching the auditory cortex. The correct sequence from the periphery to the higher centers is:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Spiral ganglion (2)</strong>: Located in Rosenthal's canal within the cochlea, the spiral ganglion contains bipolar neurons that send fibers through the cochlear nerve (part of the eighth cranial nerve) to the brainstem.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cochlear nucleus (1)</strong>: The first central auditory nucleus where the cochlear nerve fibers terminate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Superior olivary nucleus (3)</strong>: Serves as a major binaural processing center in the brainstem, crucial for localizing sounds in space.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inferior colliculus (4)</strong>: Acts as an important relay station in the midbrain, integrating auditory input before sending it to the thalamus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Medial geniculate body (5)</strong>: Part of the thalamus, this structure further processes auditory information before transmitting it to the auditory cortex.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The correct sequence of structures involved in the auditory pathway from the periphery to the center is (E COLI MA).</span></li></ul><ol><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Eighth (Vestibulocochlear) nerve</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Cochlear Nucleus</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Superior Olivary nucleus</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Lateral lemniscus</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Inferior colliculus</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Medial geniculate body</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Auditory cortex</span></p></li></ol><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_riKtGSJ.png\" width=\"500\" height=\"453\"></p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7th edition, Page No. 15</strong></span></p>",
      "correct_choice_id": 16867,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13019,
      "choices": [
        {
          "id": 52038,
          "text": "<p><span style=\"font-size:12.0pt;\">Durham's rule</span></p>"
        },
        {
          "id": 52039,
          "text": "<p><span style=\"font-size:12.0pt;\">Curren's rule</span></p>"
        },
        {
          "id": 52040,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        },
        {
          "id": 52041,
          "text": "<p><span style=\"font-size:12.0pt;\">Neither A nor B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the rules used as tests of insanity? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q6387994",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609735,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both A and B</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Durham's rule and Curren's rule are used in cases as tests for insanity.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">The Durham's rule states, “<strong>an accused is not criminally responsible if his unlawful act was the product of mental disease or mental defect</strong>”.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The Curren's rule states that “an accused person will not be criminally responsible, if at the time of committing the act, he did not have the capacity to regulate his conduct to the requirements of law, as a result of mental disease or defect”.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\">Both Durham's rule and Curren's rule are significant tests used to determine criminal responsibility in cases where the defendant's mental state is in question.</span></p>",
      "correct_choice_id": 52040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14426,
      "choices": [
        {
          "id": 57665,
          "text": "<p><span style=\"font-size:12.0pt;\">Digastric muscle</span></p>"
        },
        {
          "id": 57666,
          "text": "<p><span style=\"font-size:12.0pt;\">Sternocleidomastoid muscle</span></p>"
        },
        {
          "id": 57667,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal accessory nerve</span></p>"
        },
        {
          "id": 57668,
          "text": "<p><span style=\"font-size:12.0pt;\">Ipsilateral cervical lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient with squamous cell carcinoma of the neck undergoes radical neck dissection. Which of the following structures is typically spared during this procedure?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q4642696",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Digastric muscle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Radical neck dissection spares the digastric muscle.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The digastric muscle is typically spared during a radical neck dissection. This muscle is important for several functions, including swallowing and jaw movement.</span></li><li><span style=\"font-size:12.0pt;\">Preservation of the digastric muscle helps maintain normal swallowing and chewing abilities, which is essential for a patient's quality of life postoperatively.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A radical neck dissection is a surgical procedure that involves the removal of lymph nodes level 1 to 5, ipsilateral submandibular gland and tail of parotid, as well as other structures in the neck such as the sternocleidomastoid muscle, internal jugular vein, and spinal accessory nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In modified radical neck dissections, some structures may be spared, such as the internal jugular vein, sternocleidomastoid muscle or the spinal accessory nerve.</span></p>",
      "correct_choice_id": 57665,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10119,
      "choices": [
        {
          "id": 40442,
          "text": "<p><span style=\"font-size:12.0pt;\">21 hydroxylase deficiency</span></p>"
        },
        {
          "id": 40443,
          "text": "<p><span style=\"font-size:12.0pt;\">11 hydroxylase deficiency</span></p>"
        },
        {
          "id": 40444,
          "text": "<p><span style=\"font-size:12.0pt;\">3 beta dehydrogenase deficiency</span></p>"
        },
        {
          "id": 40445,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 lyase deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old girl was brought by her mother with complaints of enlarged clitoris. Karyotype revealed 46XX. What is the likely cause? (NEET PG 2020)</span></p>",
      "unique_key": "Q1590300",
      "question_audio": null,
      "question_video": null,
      "map_id": 13609737,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 21 hydroxylase deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario describes a 3-year-old girl with ambiguous genitalia, specifically an enlarged clitoris, and a karyotype of 46XX. This presentation is indicative of Congenital Adrenal Hyperplasia (CAH), which is most commonly caused by 21-hydroxylase deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>21-hydroxylase deficiency&nbsp;</strong>is the most common form of CAH and accounts for more than 95% of cases. This enzyme deficiency leads to impaired cortisol production, which results in an increased production of androgens. The excess androgens cause virilization, leading to ambiguous genitalia in genotypically female infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Ambiguous genitalia</strong>: This includes an enlarged clitoris, which is often a sign of virilization due to increased androgens.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Karyotype 46XX</strong>: Confirms the genetic female status.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased serum androgens</strong>: Result from the enzyme deficiency and lead to masculinization of the external genitalia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical scenario: Ambiguous genitalia in a newborn female</span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture6.jpg\" alt=\"\" width=\"236\" height=\"177\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 11 hydroxylase deficiency:&nbsp;</strong>This can also lead to CAH but is less common and typically presents with hypertension due to the accumulation of 11-deoxycorticosterone, which has mineralocorticoid activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3 beta dehydrogenase deficiency:&nbsp;</strong>This is a rarer form of CAH and typically presents with both glucocorticoid and mineralocorticoid deficiencies along with ambiguous genitalia in both sexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2, 3 lyase deficiency:&nbsp;</strong>This is not a commonly recognized cause of CAH. The primary enzyme deficiencies leading to CAH are 21-hydroxylase, 11-hydroxylase, and 17-hydroxylase deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of ambiguous genitalia in a newborn female (46XX) is 21-hydroxylase deficiency, a form of congenital adrenal hyperplasia.</span></p>",
      "correct_choice_id": 40442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}